patient_id,trial_name,decision,reason,missing_info
15452020,DECLARE_TIMI58,ELIGIBLE,"Patient is over 40, has Type 2 Diabetes, and has multiple cardiovascular risk factors. There is no indication of any exclusion criteria being met.",Confirmation of informed consent.; History of bladder cancer or radiation therapy to the lower abdomen or pelvis.
15452020,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
15452020,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criteria of being a non-insulin treated T2D patient. The patient also has a history of transient ischemic attack (TIA), which is listed as an exclusion criterion.",
10209126,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 diabetes, high risk for cardiovascular events) and does not meet any exclusion criteria.",
10209126,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.7%, which is outside the inclusion criterion range of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",Information on personal CGM use within the last 90 days; Known allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea during the study; Current participation in another interventional clinical trial; Ability to use smartphone apps; Willingness to wear CGM; Willingness to modify diet/lifestyle; Ability to read and understand English; Ability to attend study visits
10209126,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of myocardial infarction and atrial fibrillation, and is taking medications that significantly lower heart rate, violating the inclusion and exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
12678751,DECLARE_TIMI58,UNCERTAIN,"Patient meets all inclusion criteria and no definitive exclusion criteria. However, it is uncertain if the patient has chronic cystitis and/or recurrent urinary tract infections.",Confirmation regarding chronic cystitis and/or recurrent urinary tract infections
12678751,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.6%, which is outside the inclusion criteria of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.","Information on CGM usage in the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Acetaminophen dosage; Current participation in another interventional clinical trial; Suitability for participation due to comorbidities, as determined by investigator; Smartphone compatibility; Willingness to wear CGM, use apps, and make lifestyle changes; Ability to read and understand English; Ability to attend study visits"
12678751,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion for the trial.",
11429667,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes and multiple risk factors for cardiovascular events, and no listed exclusion criteria apply based on the provided data.",
11429667,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is currently taking insulin and GlipiZIDE XL which are exclusion criteria.,Smartphone availability and compatibility with CGM apps; Prior CGM use within 90 days; Willingness and ability to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Suitability for participation as determined by the investigator
11429667,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to multiple factors: The patient is 84 years old, exceeding the age limit of 70. The patient is an insulin user, which violates the inclusion criteria of non-insulin treated T2D. The patient has a history of atrial fibrillation, which is an exclusion criterion. The patient is taking carvedilol, metoprolol, and amiodarone, which are beta blockers, beta blockers, and antiarrhythmic drugs respectively, and are listed in exclusion criteria.",
10059952,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 Diabetes, and has multiple cardiovascular comorbidities suggesting high risk. No exclusion criteria are present.",
10059952,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
10059952,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being older than 70, using insulin, having symptomatic heart disease, taking a beta blocker, and having atrial fibrillation.",Duration of diabetes diagnosis; Level of physical activity
17977369,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 diabetes, and has several cardiovascular risk factors suggesting high risk for cardiovascular events. There are no indications of exclusion criteria.",
17977369,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",Smartphone compatibility with CGM apps; Prior CGM use within 90 days; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Acetaminophen dosage; Current participation in another interventional clinical trial; Severity of listed comorbidities and their impact on study participation; Suitability of skin conditions for CGM wear
17977369,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease, is taking medications that significantly lower heart rate (amiodarone and metoprolol), and has atrial fibrillation, all of which are exclusion criteria.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker; Pregnancy status
10187935,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events) and none of the exclusion criteria are met.",Confirmation of informed consent; History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis; Recurrent urinary tract infections
10187935,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.3%, which is outside the inclusion criteria range of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",Personal cellular-plan or wifi-connected smartphone compatible with required CGM apps; Prior CGM usage in the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended use of > 4g acetaminophen/day or hydroxyurea during the study; Current participation in another interventional clinical trial; Suitability for participation based on comorbidities
10187935,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to insulin use, exceeding the age limit, taking medications impacting glucose metabolism and heart rate, and has atrial fibrillation.",Diabetes diagnosis date; Physical activity level; Severity of heart disease; Use of pacemaker
13974607,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes, and comorbidities indicate high cardiovascular risk. Patient is male and so does not meet the pregnant/breast-feeding exclusion criteria. No indication of Type 1 Diabetes or history of bladder cancer/radiation. Other exclusion criteria information requires confirmation.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
13974607,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.85%, which is outside the inclusion criterion range of 7.0%-10.0%. Also, the patient is currently taking insulin and Repaglinide, which are exclusion criteria.",
13974607,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
10933538,DECLARE_TIMI58,INELIGIBLE,"The patient has Stage 4 and Stage 5 Chronic Kidney Disease, which indicates a high likelihood of renal manifestations of diabetes, but the patient also has Type 2 diabetes mellitus without complications and with other specified manifestations (not uncontrolled), meaning the diabetes is controlled. However, a listed medication is Metformin and the patient's eGFR is 24.4 which makes them ineligible. While the other inclusion criteria are met (age >= 40, diagnosis of Type 2 Diabetes, and High Risk for Cardiovascular events based on numerous comorbidities such as heart failure and hypertension) and no exclusion criteria are directly violated (no bladder cancer history, no pregnancy, no Type 1 Diabetes), the patient is on Metformin and has an eGFR of 24.4 which makes the patient ineligible. Additionally, they have diabetes with renal manifestations and diabetes with other specified manifestations with is not stated as uncontrolled. However, other medications could potentially cause kidney problems.",
10933538,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
10933538,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being over the age limit (75 vs max 70), insulin use, use of medications that affect heart rate and glucose metabolism, and atrial fibrillation.",Date of diabetes diagnosis; Physical activity level
15159308,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria for age, T2DM, and high cardiovascular risk. No explicit exclusion criteria are present; however, it is UNCERTAIN if the patient has chronic cystitis/recurrent UTIs.",Information on whether the patient has chronic cystitis and/or recurrent UTIs.
15159308,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.8%, which is outside the inclusion criteria of 7.0%-10.0%. The patient is also taking insulin and Glipizide XL, which are exclusion criteria.",Personal cellular-plan or wifi-connected smartphone availability and compatibility; Prior CGM use within 90 days; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended use of >4g acetaminophen/day or hydroxyurea; Current participation in another interventional clinical trial; Suitability for participation due to comorbidities
15159308,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, a history of myocardial infarction, current use of oral steroids (Prednisone), current use of beta blockers (Metoprolol Succinate XL and Metoprolol Tartrate), and atrial fibrillation.",Diabetes diagnosis date; Pacemaker use; Physical activity level
19359798,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria. High risk for cardiovascular events is likely given comorbidities, but the presence of urinary tract infection needs clarification to determine if it is chronic cystitis or recurrent UTIs which would exclude the patient.",Confirmation of whether the patient's urinary tract infection is chronic cystitis and/or recurrent UTIs.
19359798,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (Insulin Human Regular), which is an exclusion criterion.",smartphone availability/compatibility; prior CGM use within 90 days; willingness to wear CGM and use apps; willingness to make diet/lifestyle modifications; ability to read and understand English; ability to attend study visits; allergy to medical grade adhesive or isopropyl alcohol; skin conditions; acetaminophen/hydroxyurea usage; current participation in another interventional clinical trial; investigator assessment of suitability
19359798,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of heart disease, uses beta-blockers, and has atrial fibrillation. Therefore, they do not meet the inclusion criterion for non-insulin treated T2D and meet multiple exclusion criteria related to symptomatic heart disease, heart rate lowering medications, and atrial fibrillation.",Time since diabetes diagnosis; Physical activity level
12257261,DECLARE_TIMI58,ELIGIBLE,"The patient is a 63-year-old male with Type 2 diabetes and high risk for cardiovascular events, and has no conditions listed in the exclusion criteria.",
12257261,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c (10.2%) is outside the inclusion criteria range (7.0-10.0%). Also, the patient is using insulin, which is both an exclusion criterion and violates the medication requirements in the inclusion criteria.",Smartphone compatibility; Prior CGM use (90 days); Willingness to wear CGM; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Acetaminophen dosage; Allergy to adhesives or isopropyl alcohol; Skin conditions incompatible with CGM wear; Participation in another interventional trial; Investigator assessment of suitability due to comorbidities
12257261,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin. The inclusion criteria require non-insulin treated T2D. Additionally, the patient's HbA1c is 10.2, while the inclusion criteria require HbA1c below 8.5.",
16077678,DECLARE_TIMI58,ELIGIBLE,"The patient is male, over 40 years old, has Type 2 Diabetes, and is at high risk for cardiovascular events based on co-morbidities. There is no evidence of any of the exclusion criteria.",
16077678,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.85%, which is below the required range of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",Smartphone Compatibility; Prior CGM Use; Willingness to Wear CGM and Use Apps; Willingness to make diet/lifestyle modifications; Ability to Read/Understand English; Ability to Attend Study Visits; Acetaminophen Dosage; Participation in other interventional clinical trials; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear
16077678,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, which violates the inclusion criteria of being non-insulin treated.",Physical activity level (minutes/week of moderate activity); Diabetes diagnosis date; Use of an electronic pacemaker
14975577,DECLARE_TIMI58,ELIGIBLE,"The patient is a female, aged 66 years, has type 2 diabetes, and multiple comorbidities indicating high risk for cardiovascular events. There's no indication of bladder cancer or radiation therapy. There is a history of a UTI, however it is unspecified if the infection is chronic or recurrent. It can be assumed that the patient does not meet the pregnancy exclusion criteria due to age.",
14975577,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.36%, which is below the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
14975577,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion of being a non-insulin treated T2D patient.",
19620469,DECLARE_TIMI58,INELIGIBLE,"Patient does not meet the age inclusion criterion (age < 40) and has a diagnosis of Type 1 Diabetes Mellitus, which is an exclusion criterion.",
19620469,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient is currently taking insulin and GlipiZIDE, which are listed as exclusion criteria.",
19620469,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age, HbA1c level, use of insulin, symptomatic heart disease, oral steroid use, and beta blocker use.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status
12390082,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events) and none of the exclusion criteria.",
12390082,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. The medications list includes 'Insulin'.",
12390082,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are currently using insulin. The inclusion criteria require that patients be non-insulin treated for their T2D, or only treated with metformin.",
19681724,DECLARE_TIMI58,INELIGIBLE,"The patient has a diagnosis of both Type 1 and Type 2 diabetes mellitus, making them ineligible due to the exclusion criteria for Type 1 diabetes.",
19681724,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
19681724,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has a high HbA1c (8.74%), and takes metoprolol (a beta blocker), all of which are exclusion criteria.",Duration of T2D diagnosis; Level of physical activity
18039866,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes diagnosis) and does not meet any exclusion criteria (no Type 1 diabetes, no bladder cancer history or radiation to lower abdomen/pelvis, no chronic cystitis or recurrent UTIs, not pregnant or breastfeeding). High risk for cardiovascular events is assumed given the patient's history of pulmonary embolism, atrial fibrillation, hypertension, hyperlipidemia, and atherosclerosis.",
18039866,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and metformin, which are exclusionary medications based on the trial's exclusion criteria.",
18039866,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin (Insulin; MetFORMIN XR (Glucophage XR)), which violates the inclusion criterion of being non-insulin treated. Additionally, the patient has atrial fibrillation, which is an exclusion criterion.",
18260419,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, likely high risk for cardiovascular events based on comorbidities) and none of the exclusion criteria.",
18260419,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.43%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
18260419,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are a long-term insulin user, take Prednisone (an oral steroid), and take Nadolol (a beta blocker). These factors violate the inclusion/exclusion criteria regarding insulin use and medication usage.",Diabetes diagnosis date; Atrial fibrillation status; Use of an electronic pacemaker; Physical activity level
13336130,DECLARE_TIMI58,ELIGIBLE,"The patient is a 71-year-old male with Type 2 diabetes and multiple cardiovascular conditions, indicating a high risk for cardiovascular events. The patient meets all inclusion criteria and none of the exclusion criteria.",
13336130,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.9%, which is below the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin which is an exclusion criteria.",
13336130,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 71 years old, which is older than the maximum age of 70 for inclusion. They are also using insulin, carvedilol, labetalol and dexamethasone, and have a history of cardiac events, which are all exclusion criteria.",Diabetes diagnosis date; Physical activity level; Atrial fibrillation status; Use of an electronic pacemaker
13061944,DECLARE_TIMI58,INELIGIBLE,"Patient has a diagnosis of both Type 1 and Type 2 diabetes mellitus, but the presence of Type 1 diabetes is an exclusion criterion.",
13061944,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",Smartphone Compatibility; Prior CGM Use; Allergy to adhesives/alcohol; Skin Conditions; Acetaminophen/Hydroxyurea Use >4g daily; Participation in Other Trials; Willingness to Use CGM; Willingness to Modify Diet/Lifestyle; English Literacy; Attendance at Study Visits
13061944,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, is outside the age range for the trial, uses oral steroids, and uses medications that lower heart rate, all of which are exclusion criteria. The patient is also outside the age range.",Duration of diabetes diagnosis; Level of physical activity
18904237,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and T2D criteria, and is at high risk for cardiovascular events. No indication of exclusion criteria. Informed consent not documented.",Documentation of informed consent
18904237,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.16%, which is outside the inclusion criteria of 7.0%-10.0%. The patient is also currently using insulin, which is an exclusion criterion.","Has the patient used a personal CGM in the 90 days prior to consent?; Intended use of acetaminophen > 4g/day during the study?; Is the patient suitable for participation considering significant comorbidities, as determined by Investigator?; Does the patient have a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study?"
18904237,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently treated with insulin, which is an exclusion criteria. Also, HbA1c is 10.16, which is above the inclusion criteria of HbA1c below 8.5%.",
13235748,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria, but information regarding history of bladder cancer or radiation therapy to the lower abdomen/pelvis and chronic cystitis and/or recurrent urinary tract infections is missing. If the patient has a history of bladder cancer or radiation therapy to the lower abdomen/pelvis or has chronic cystitis and/or recurrent urinary tract infections, they are ineligible.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis; Recurrent urinary tract infections
13235748,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and acarbose, which are listed as exclusionary medications in the exclusion criteria.",CGM usage in the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended acetaminophen or hydroxyurea use; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
13235748,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion that they must be non-insulin treated. Additionally, they are taking metoprolol, which is a beta-blocker and thus an exclusion criterion.",
17541404,DECLARE_TIMI58,ELIGIBLE,"Patient is 50 years old, has Type 2 diabetes, and does not meet any exclusion criteria. Risk of CVD events is implied by their T2DM and age.",
17541404,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 5.23% (must be 7.0%-10.0%), and the patient is taking Insulin and Metformin, which is an exclusion criterion.","Whether patient has used a personal CGM within 90 days; Whether the patient has known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin; Whether the patient has skin conditions that are not compatible with CGM wear; Patient Acetaminophen use; Whether the patient is planning to become pregnant, pregnant, or lactating; Current participation in another interventional clinical trial; Ability to read and understand English; Willingness to make diet/lifestyle modifications; Whether the patient is able to attend study visits and complete the requirements of study; Whether the patient has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps"
17541404,NCT06864546_Glutotrack,INELIGIBLE,"The patient is using insulin, excluding them based on the inclusion criteria of being non-insulin treated, and the patient is taking propranolol which is a beta-blocker which excludes the patient based on exclusion criteria.",Physical activity level; Duration of diabetes diagnosis; Pregnancy status; Use of an electronic pacemaker
10577868,DECLARE_TIMI58,UNCERTAIN,"The patient has cystitis, unspecified with hematuria. The chronicity or recurrence of urinary tract infections is unknown. This needs clarification to determine eligibility.",
10577868,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.37%, which is outside the inclusion criterion of 7.0%-10.0%.","Whether the patient has a compatible smartphone with cellular plan or wifi access; Whether the patient has used a personal CGM system within 90 days; Patient's willingness and ability to wear CGM and use associated apps; Patient's willingness and ability to make diet/lifestyle modifications in response to CGM data; Patient's ability to read and understand English; Patient's ability to attend study visits and complete the requirements of study; Whether the patient is planning to take insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk in the future.; Whether the patient has known allergies to medical grade adhesive or isopropyl alcohol; Whether the patient has skin conditions that are not compatible with CGM wear; Whether the patient intends to use > 4g acetaminophen/day or hydroxyurea during the study; Whether the patient is planning to become pregnant, pregnant, or lactating.; Whether the patient is participating in another interventional clinical trial; Investigator determination of suitability considering comorbidities"
10577868,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, oral steroids (Methylprednisolone and Prednisone) and Labetalol, which are all exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Patient's physical activity level
16423028,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40 years old, has type 2 diabetes, and has multiple cardiovascular conditions indicating high risk. The patient does not have a history of type 1 diabetes, bladder cancer, radiation therapy to the lower abdomen/pelvis, chronic cystitis and/or recurrent urinary tract infections, and is not pregnant or breast-feeding.",
16423028,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.92%, which is below the required range of 7.0%-10.0%. Additionally, the patient is taking insulin, which is an exclusion criterion.",Confirmation of stable dose diabetes medication; CGM usage within the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Intended acetaminophen use; Current participation in another interventional clinical trial; Ability to read and understand English; Ability to attend study visits and complete the requirements of study; Access to and comfort with smartphone technology to use CGM apps; Willingness to modify diet and lifestyle based on CGM data
16423028,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to current insulin use, age over 70, history of heart failure, dexamethasone use, metoprolol/amiodarone use, and atrial fibrillation.",Diabetes diagnosis date; Physical activity level; Use of an electronic pacemaker
12773948,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and T2DM criteria. The patient appears to be at high risk for cardiovascular events. The patient does not meet the exclusion criteria for T1DM, bladder cancer/radiation, or chronic cystitis/UTIs. However, pregnancy/breastfeeding status is unknown.",Pregnancy/Breastfeeding Status
12773948,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.2%, which falls outside the inclusion criteria of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
12773948,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently prescribed insulin, has a history of myocardial infarction, is taking dexamethasone, and is taking beta blockers (Metoprolol Succinate XL, Metoprolol Tartrate and Labetalol). These factors exclude them from the trial.",Diabetes diagnosis date; Pregnancy status; Physical Activity Level; Use of an electronic pacemaker
13639034,DECLARE_TIMI58,ELIGIBLE,"Patient meets the inclusion criteria for age >= 40, Type 2 Diabetes diagnosis, and high risk for cardiovascular events. Patient does not meet any of the exclusion criteria.",
13639034,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 11.49%, which is outside the inclusion criteria range of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
13639034,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has HbA1c above 8.5%, has a history of myocardial infarction, uses oral steroids, uses medications that lower heart rate, has atrial fibrillation, and has an electronic pacemaker. Thus, the patient does not meet the inclusion criteria and violates multiple exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
13545585,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria: age >=40, diagnosed with Type 2 Diabetes (presence of several Type 2 Diabetes diagnoses in comorbidities), and high risk for cardiovascular events (multiple heart failure diagnoses and atherosclerotic heart disease). Patient does not meet any exclusion criteria.",
13545585,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (Regular), which is an exclusion criterion.",
13545585,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, age over 70, HbA1c above 8.5, history of myocardial infarction, use of oral steroids (Prednisone and MethylPREDNISolone Sodium Succ), use of a beta blocker (Carvedilol), and atrial fibrillation.",Diabetes diagnosis date; Level of physical activity; Use of an electronic pacemaker
19519548,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes, and has multiple cardiovascular risk factors (e.g., congestive heart failure, myocardial infarction, atrial fibrillation, coronary atherosclerosis, hyperlipidemia). Patient does not have any listed exclusion criteria (no mention of Type 1 diabetes, bladder cancer, radiation therapy to the lower abdomen or pelvis, chronic cystitis, recurrent UTIs, pregnancy, or breastfeeding).",
19519548,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.9%, which is below the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
19519548,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has a history of symptomatic heart disease, atrial fibrillation, and is using a beta-blocker. All are exclusion criteria for the trial.",Date of T2D diagnosis; Level of physical activity; Use of electronic pacemaker
16296020,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has Type 2 Diabetes Mellitus, and has a high risk for cardiovascular events. The patient does not have Type 1 Diabetes Mellitus, bladder cancer, radiation therapy to the lower abdomen/pelvis, chronic cystitis, recurrent urinary tract infections, is not pregnant or breastfeeding.",
16296020,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is taking insulin (as indicated by 'insulin_user': true and presence of 'Insulin' in current medications) and GlipiZIDE XL which is a sulfonylurea. Both of these are exclusion criteria.,
16296020,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 79 years old, exceeding the maximum age of 70. Patient is also an insulin user, excluding them from the trial criteria of being a non-insulin treated T2D patient.",Physical activity level; Time of diabetes diagnosis; Confirmation that the cerebrovascular disease was not an ischemic event; Use of an electronic pacemaker
12453404,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria. However, it's uncertain whether the patient has chronic cystitis and/or recurrent urinary tract infections, and the pregnancy status is unknown, both of which are exclusion criteria.",Confirmation of absence of chronic cystitis and recurrent urinary tract infections; Pregnancy status
12453404,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is explicitly listed as an insulin user. The exclusion criteria state that patients taking any form of insulin are ineligible.,
12453404,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently being treated with insulin, Prednisone, Clonidine, Nadolol, and Metoprolol Tartrate making them ineligible based on the inclusion and exclusion criteria.",Date of diabetes diagnosis; Pregnancy status; Presence of symptomatic heart disease; Physical activity level; Pacemaker use; Atrial Fibrillation diagnosis
14396488,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events) and none of the exclusion criteria.",
14396488,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
14396488,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of heart disease (coronary angioplasty) and is taking PredniSONE (an oral steroid), making them ineligible. Additionally, the patient is taking Hydrochlorothiazide, a medication that *can* lower heart rate, further supporting a decision of ineligibility.",Diabetes diagnosis date; Physical activity level (minutes/week); Atrial fibrillation status; Use of electronic pacemaker
17805187,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria of age, type 2 diabetes, and high risk for cardiovascular events. The patient is male, thus the pregnancy exclusion criteria is not met. The patient has a urinary tract infection, but it is unclear if the patient has chronic cystitis and/or recurrent urinary tract infections. Also, it is not known if the patient has a history of bladder cancer or radiation therapy to the lower abdomen or pelvis at any time.",History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis; Presence of chronic cystitis and/or recurrent urinary tract infections
17805187,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
17805187,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin and has an HbA1c above 8.5%. They also have symptomatic heart disease and are on medications that significantly lower heart rate (Carvedilol, Diltiazem).",Duration of diabetes diagnosis; Physical activity level
18851503,DECLARE_TIMI58,ELIGIBLE,"The patient is >=40 years old, diagnosed with Type 2 Diabetes, and likely high risk for cardiovascular events (based on comorbidities such as hypertension, hyperlipidemia). The patient does not have any of the listed exclusion criteria (no T1DM, bladder cancer history, radiation to lower abdomen/pelvis, chronic cystitis/UTIs, or pregnancy/breastfeeding).",
18851503,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.7%, which falls outside the inclusion criterion of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",
18851503,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin, which violates the inclusion criterion of being non-insulin treated.",Duration of diabetes diagnosis; Patient's physical activity level; Detailed cardiac evaluation for symptomatic heart disease; Confirmation of medication effects on heart rate
19337609,DECLARE_TIMI58,UNCERTAIN,"The patient is listed as having both Type 1 and Type 2 diabetes, which is contradictory and makes eligibility determination impossible without clarification.","Confirmation of diabetes type (Type 1 or Type 2, not both)"
19337609,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is explicitly listed as having 'Long term (current) use of insulin'. This violates the exclusion criterion regarding insulin use.,
19337609,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, has a history of symptomatic heart disease, uses medications that significantly lower heart rate, and has been diagnosed with atrial fibrillation, all of which are exclusion criteria.",Level of physical activity; Duration of diabetes diagnosis; Use of an electronic pacemaker
16405709,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events inferred from multiple cardiovascular comorbidities). Patient does not meet any exclusion criteria (no T1DM, bladder cancer, radiation therapy to lower abdomen/pelvis, chronic cystitis/recurrent UTIs, or pregnancy/breastfeeding).",
16405709,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.55%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
16405709,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which is a disqualifying factor based on the exclusion criteria.",
18149759,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria.",
18149759,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.16%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is taking insulin, which is an exclusion criterion.",
18149759,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being over the age limit (81 years old), using insulin, having a history of symptomatic heart disease and atrial fibrillation, and taking beta blockers.",Diabetes diagnosis date; Pregnancy status; Use of oral steroids; Use of electronic pacemaker; Physical activity levels
16288189,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes inclusion criteria and appears to be at high risk for cardiovascular events. The patient is male and does not meet the exclusion criterion of pregnancy/breastfeeding. However, the presence or absence of bladder cancer history/radiation to the lower abdomen/pelvis, as well as confirmation that the patient's UTI is not chronic or recurrent, cannot be determined from the provided data. The provision of informed consent is also unknown.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Confirmation of whether the patient has chronic cystitis and/or recurrent urinary tract infections; Confirmation of informed consent
16288189,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
16288189,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, age greater than 70 years, history of myocardial infarction and aortocoronary bypass, use of medications that significantly lower heart rate and atrial fibrillation.",Physical activity level; Diabetes diagnosis date; Use of an electronic pacemaker
17375120,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and T2DM inclusion criteria and likely meets the high-risk cardiovascular event criteria. However, eligibility is uncertain due to the urinary tract infection comorbidity (potentially indicating chronic cystitis or recurrent UTIs) and missing information regarding history of bladder cancer/radiation and informed consent.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Informed consent status; Chronicity of urinary tract infection
17375120,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.2%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is an insulin user, which is an exclusion criterion.",
17375120,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age (77, exceeding the maximum age of 70), use of insulin, and history of atrial fibrillation. The patient also uses amiodarone and metoprolol, which are excluded medications.",
10142213,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has Type 2 diabetes, and multiple conditions indicating a high risk for cardiovascular events. The patient does not have any of the listed exclusion criteria.",
10142213,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
10142213,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently using insulin, which is an exclusion. Patient also has an HbA1c of 8.65%, above the inclusion criteria limit of 8.5%. The patient is also taking Metoprolol, which is a beta blocker and an exclusion.",Duration of diabetes diagnosis; Information on physical activity levels; History of symptomatic heart disease; Use of an electronic pacemaker
16754247,DECLARE_TIMI58,UNCERTAIN,"The patient has Type 2 diabetes, is over 40, and appears to be at high risk for cardiovascular events. However, the patient takes medications suggestive of chronic cystitis and/or recurrent urinary tract infections, which is an exclusion criterion. Additionally, the patient's pregnancy status is unknown.",confirmation of chronic cystitis and/or recurrent urinary tract infections; pregnancy status
16754247,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
16754247,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, has history of coronary angioplasty implant and graft and atrial fibrillation, and takes both Metoprolol Tartrate and Verapamil. All of these constitute reasons for exclusion.",Physical activity level; Diabetes diagnosis date; Pregnancy status
13902721,DECLARE_TIMI58,ELIGIBLE,"The patient is a 79-year-old male with Type 2 Diabetes and multiple cardiovascular risk factors, meeting all inclusion criteria. There are no indications of any exclusion criteria.",
13902721,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 11.57%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",Smartphone compatibility; Recent CGM use (within 90 days); Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to adhesive/alcohol; Skin conditions incompatible with CGM; Dosage of Acetaminophen; Participation in another interventional clinical trial
13902721,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to age greater than 70, HbA1c greater than 8.5%, insulin use, history of heart disease, atrial fibrillation, and use of multiple heart-rate lowering medications.",Duration of diabetes diagnosis; Level of physical activity; Use of electronic pacemaker
12088749,DECLARE_TIMI58,ELIGIBLE,"Patient meets the age and Type 2 diabetes inclusion criteria. Based on medications and comorbidities, it is likely the patient is at high risk for cardiovascular events. No exclusion criteria are definitively met.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
12088749,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.29%, which falls outside the inclusion criterion range of 7.0%-10.0%.",
12088749,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking PredniSONE, an oral steroid, which is an exclusion criterion.",Physical activity level; Duration of diabetes diagnosis; Pregnancy status; Use of an electronic pacemaker
13162333,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria, and is not explicitly excluded by any of the exclusion criteria. However, the patient has a 'Urinary tract infection, site not specified' listed as a comorbidity, and it's uncertain if this is chronic or recurrent. The patient lacks information on a history of bladder cancer or radiation therapy to the lower abdomen or pelvis.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Is the urinary tract infection chronic or recurrent?
13162333,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.17%, which is outside the inclusion criterion range of 7.0%-10.0%. Additionally, the patient is currently taking insulin and GlipiZIDE XL which are exclusion criteria.",
13162333,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, takes oral steroids, is taking multiple medications that significantly lower heart rate, has symptomatic heart disease, and atrial flutter, thus violating the inclusion and exclusion criteria.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker
12759279,DECLARE_TIMI58,UNCERTAIN,The patient meets the age and diabetes inclusion criteria and appears to have a high risk for cardiovascular events. The patient is male so pregnancy/breastfeeding is not relevant. The patient does not have a diagnosis of Type 1 diabetes. It is uncertain whether the patient had radiation therapy to the lower abdomen or pelvis and whether the patient has chronic cystitis and/or recurrent urinary tract infections.,History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
12759279,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking Insulin and Glipizide, both of which are exclusion criteria.",CGM usage in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps and consistent availability; Willingness to wear CGM and use CGM mobile apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete study requirements
12759279,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, has several exclusion criteria related to heart conditions, is taking oral steroids, is on medications that significantly lower heart rate, and has atrial fibrillation.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
18942307,DECLARE_TIMI58,ELIGIBLE,"Patient is between 40-80 years old, has Type 2 Diabetes, and based on the available comorbidities, appears to be at high risk for cardiovascular events. The patient does not appear to meet any exclusion criteria.",
18942307,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.34%, which is above the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
18942307,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 10.34%, which is above the inclusion criterion of HbA1c below 8.5%. Also, the patient is currently treated with insulin, violating the inclusion criteria of non-insulin treated T2D.",
12435152,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes type inclusion criteria, and has no listed exclusions for bladder cancer, radiation therapy, type 1 diabetes or pregnancy. However, the patient has a Urinary tract infection, site not specified, which could suggest chronic cystitis and/or recurrent urinary tract infections. Also, high risk for cardiovascular events is assumed because of heart failure, but this is not explicitly mentioned.",Confirmation on whether the patient has chronic cystitis and/or recurrent UTIs.; Confirmation of patient's cardiovascular risk status.
12435152,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
12435152,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion of being non-insulin treated.",Physical activity level; Duration of diabetes diagnosis
13543193,DECLARE_TIMI58,ELIGIBLE,"The patient is 58 years old, diagnosed with Type 2 Diabetes, and has several comorbidities indicating a high risk for cardiovascular events. The patient does not have any exclusion criteria such as Type 1 diabetes, history of bladder cancer or radiation to the lower abdomen/pelvis, chronic cystitis/UTIs, or pregnancy/breastfeeding.",
13543193,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
13543193,NCT06864546_Glutotrack,INELIGIBLE,The patient is an insulin user and takes Metoprolol Tartrate (a beta blocker).,Diabetes diagnosis date; Details regarding any prior symptomatic heart disease; Use of an electronic pacemaker; Physical activity level
18203607,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and T2DM inclusion criteria and appears to be at high risk for cardiovascular events. There is no evidence of Type 1 diabetes or history of bladder cancer/radiation therapy. However, it is uncertain if the patient has 'chronic cystitis and/or recurrent urinary tract infections.' Additionally, while unlikely given the patient's age, pregnancy status cannot be confirmed.",Informed consent documentation; Information on history of chronic cystitis and/or recurrent urinary tract infections; Pregnancy status
18203607,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.38%, which falls outside the inclusion criterion range of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",
18203607,NCT06864546_Glutotrack,INELIGIBLE,"The patient is explicitly listed as an insulin user, and the trial's inclusion criteria specify non-insulin treated T2D.",
10678253,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and T2DM inclusion criteria, and appears to be at high risk for cardiovascular events, and does not appear to violate any exclusion criteria. However, informed consent cannot be verified based on the information provided.",Confirmation of informed consent
10678253,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",HbA1c value; CGM usage in the past 90 days; Smartphone availability and compatibility; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete the requirements of study; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Current participation in another interventional clinical trial; Acetaminophen dosage; Investigator suitability assessment
10678253,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. The patient also uses Amiodarone which significantly lowers heart rate, and is therefore an exclusion criteria. The patient also has atrial fibrillation, which is an exclusion criteria.",
11366422,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria of age, type 2 diabetes, and high risk for cardiovascular events. However, information regarding history of bladder cancer or radiation therapy to the lower abdomen or pelvis, chronic cystitis and/or recurrent urinary tract infections, and pregnancy/breastfeeding status is missing. These missing data points prevent a definitive eligibility determination.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections; Pregnancy/breastfeeding status
11366422,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. Also, the HbA1c is missing, making it impossible to verify inclusion criteria.",CGM usage within the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended Acetaminophen use; Pregnancy status; Participation in other interventional clinical trials; Smartphone compatibility; Willingness to wear CGM; Willingness to modify lifestyle; English literacy; Ability to attend study visits
11366422,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of symptomatic heart failure, and is taking medications that significantly impact glucose metabolism (oral steroids) and lower heart rate (calcium channel blockers, clonidine, labetalol).",Physical activity level; Duration of diabetes diagnosis; Pregnancy status; Atrial fibrillation status; Use of electronic pacemaker; HbA1c
11055094,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of radiation therapy to the lower abdomen or pelvis, which leads to irradiation cystitis (a form of chronic cystitis), meeting one of the exclusion criteria.",
11055094,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient is taking insulin, which is an exclusion criterion. Also, HbA1c is 5.4% which is outside the inclusion criteria range of 7.0%-10.0%.",
11055094,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, Prednisone and Metoprolol. Additionally, the patient has a history of atrial fibrillation, all of which are exclusion criteria for the study.",Duration of diabetes diagnosis; Level of physical activity; Use of an electronic pacemaker
10383515,DECLARE_TIMI58,ELIGIBLE,"The patient is 65 years old, has Type 2 diabetes, and has comorbidities suggesting high cardiovascular risk. The patient does not meet any of the exclusion criteria.",
10383515,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.7%, which is above the inclusion criterion of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.","Does the patient have a smartphone with a cellular plan or wifi, compatible with CGM apps, and consistently available?; Has the patient used a CGM in the past 90 days?; Is the patient willing to wear a CGM, use the associated mobile apps, make diet/lifestyle modifications, and attend study visits and complete the requirements?; Can the patient read and understand English?; Is the patient planning to become pregnant, pregnant, or lactating?; Is the patient currently participating in another interventional clinical trial?"
10383515,NCT06864546_Glutotrack,INELIGIBLE,Patient uses insulin and has an HbA1c of 10.7%. Also using medications impacting glucose metabolism (Iso-Osmotic Dextrose; Glucose Gel; Dextrose 50%) and lowering heart rate (HydrALAzine).,Duration of diabetes diagnosis; Level of physical activity
10880317,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 Diabetes, and has a history of myocardial infarction and heart failure indicating high risk for cardiovascular events. There are no exclusion criteria present.",
10880317,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking Insulin, which is an exclusion criterion. The patient's HbA1c is missing and is required for enrollment. The patient's existing comorbidities also make eligibility uncertain.",Smartphone compatibility with CGM apps; Willingness to wear CGM/use apps/modify lifestyle/attend visits; English comprehension; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended use of > 4g acetaminophen/day or hydroxyurea during the study; Current participation in another interventional clinical trial
10880317,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of myocardial infarction, and takes medications that lower heart rate and has atrial fibrillation. These factors violate exclusion criteria.",Duration of diabetes diagnosis; Level of physical activity; Use of electronic pacemaker
14470662,DECLARE_TIMI58,UNCERTAIN,"The patient meets all inclusion criteria. However, the absence of information regarding a history of bladder cancer, radiation therapy to the lower abdomen or pelvis, and chronic cystitis/recurrent UTIs makes the eligibility uncertain.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
14470662,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Smartphone compatibility; Prior CGM use in 90 days; Willingness to wear CGM; Willingness to modify diet/lifestyle; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Participation in another interventional clinical trial
14470662,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criteria that states ""Non-insulin treated T2D diagnosis (not treated at all or only with metformin)"". Additionally, the patient has a history of non-ST elevation (NSTEMI) myocardial infarction and atherosclerotic heart disease, which violates the exclusion criterion related to symptomatic heart disease.",
14458750,DECLARE_TIMI58,UNCERTAIN,"The patient's comorbidities list both Type 1 and Type 2 diabetes. If the patient has both, they are ineligible. Clarification is needed regarding the conflicting diagnoses of type 1 and type 2 diabetes.","Confirmation of the patient's current diabetes type (Type 1, Type 2, or both)."
14458750,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",Smartphone availability and compatibility with CGM apps; Prior CGM use within 90 days; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Investigator assessment of suitability
14458750,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently using insulin and HbA1c is 9.67%, which is above the limit of 8.5%. Also has a history of TIA, which is an exclusion criteria.",Diabetes diagnosis date; Pregnancy status; Use of electronic pacemaker; Physical activity levels; Determine whether Lisinopril significantly lowers heart rate
16966974,DECLARE_TIMI58,ELIGIBLE,"Patient is female, aged 41 years, diagnosed with Type 2 Diabetes, and appears to be at high risk for cardiovascular events. There is no indication of any exclusion criteria being met, although pregnancy/breastfeeding status is unknown.",Confirmation of informed consent; Pregnancy/breastfeeding status
16966974,NCT05928572_CGM_Initiation,INELIGIBLE,Patient is ineligible due to HbA1c being outside the range of 7.0%-10.0% and the patient is taking insulin.,personal cellular-plan or wifi-connected smartphone availability and compatibility; CGM use within 90 days; willingness and ability to wear CGM and use apps; willingness and ability to make diet/lifestyle modifications; ability to read and understand English; ability to attend study visits; allergy to medical grade adhesive or isopropyl alcohol; skin conditions; acetaminophen dosage; pregnancy status; participation in other interventional clinical trials; investigator determination of suitability
16966974,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to current insulin use, HbA1c above 8.5%, and the use of an oral steroid (PrednisoLONE Acetate).",Duration of diabetes diagnosis; Physical activity level; Pregnancy status
10037928,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of cystitis and urinary tract infections, meeting the exclusion criteria for chronic or recurrent urinary tract infections.",
10037928,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. Also, the patient's HbA1c is 10.38%, which is outside the inclusion range of 7.0%-10.0%.",
10037928,NCT06864546_Glutotrack,INELIGIBLE,"Patient is being treated with insulin (violates inclusion), age is 78 (violates inclusion), HbA1c is 10.38% (violates inclusion), and the patient is taking oral steroids (Prednisolone Acetate and Dexamethasone) and beta blockers (Propranolol and Metoprolol) that are exclusionary.",Diabetes diagnosis date; Pregnancy status; Pacemaker use; Detailed cardiac history
13627462,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria (no Type 1 diabetes, bladder cancer/radiation, chronic cystitis/UTIs, pregnancy/breastfeeding).",
13627462,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which violates the exclusion criterion of taking insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk.",CGM usage within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
13627462,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to age being over 70, insulin use, history of symptomatic heart disease, use of medications that lower heart rate, and atrial fibrillation.",Physical activity level; Diabetes diagnosis date; Use of electronic pacemaker
17147107,DECLARE_TIMI58,ELIGIBLE,"The patient is >=40 years old, has Type 2 diabetes, and has multiple risk factors indicating high cardiovascular risk. The patient does not meet any exclusion criteria.",
17147107,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
17147107,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which is an exclusion criterion. The patient's medication list contains 'Insulin'.",
11209839,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age and diagnosis of Type 2 diabetes. High risk for cardiovascular events can be assumed. However, information on bladder cancer/radiation therapy history, chronic cystitis/UTIs, and current pregnancy/breastfeeding status are missing, creating uncertainty.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections; Pregnancy or breastfeeding status
11209839,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
11209839,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. The patient also has atrial fibrillation, which is another exclusion criterion.",
15078964,DECLARE_TIMI58,UNCERTAIN,"The patient has a history of urinary tract infections, but it's unclear whether they are chronic or recurrent, which is an exclusion criterion.",Confirmation of whether the patient has chronic cystitis and/or recurrent urinary tract infections.
15078964,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 5.92%, which is outside the inclusion range of 7.0-10.0%. Patient is also taking insulin, which is an exclusion criterion.",Personal cellular-plan or wifi-connected smartphone?; CGM use within 90 days?; Allergy to medical grade adhesive or isopropyl alcohol?; Skin conditions?; Acetaminophen/hydroxyurea use?; Current participation in another interventional clinical trial?; Investigator determination of suitability?
15078964,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which violates the inclusion criterion stating 'Non-insulin treated T2D diagnosis'. Additionally, the patient has a history of 'Old myocardial infarction' and 'Other persistent atrial fibrillation', both of which are exclusion criteria for the trial.",
13911546,DECLARE_TIMI58,INELIGIBLE,"Patient is ineligible because they are 36 years old, which is less than the minimum age of 40, and they are diagnosed with Type 1 diabetes mellitus.",
13911546,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is taking insulin and has a history of type 1 and type 2 diabetes. The trial excludes patients taking insulin or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk. The patient's HbA1c is also above the limit specified by the inclusion criteria.,
13911546,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being outside the age range, having an HbA1c above 8.5%, insulin use, a history of heart failure, and use of Clonidine and Metoprolol.",Duration of diabetes diagnosis; Physical activity level
18769881,DECLARE_TIMI58,INELIGIBLE,"The patient is 32 years old, which is below the age requirement of 40 years or older.",
18769881,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",
18769881,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible for several reasons: the patient's age (32) is not between 40 and 70; the patient's HbA1c (9.73) is not below 8.5%; and the patient is an insulin user, which is an exclusion criterion because the inclusion criteria specifies non-insulin treated T2D.",
13168133,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age, type 2 diabetes, and high cardiovascular risk inclusion criteria. They also do not meet any of the listed exclusion criteria. However, it is not known if the patient has provided informed consent.",Provision of informed consent
13168133,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking Empagliflozin, which is an anti-hyperglycemic diabetes medication. The exclusion criteria states that patients currently taking or planning to take any form of insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk are ineligible.",
13168133,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking Empagliflozin, an anti-diabetic medication other than metformin, which violates the non-insulin-treated T2D criteria. They also have symptomatic heart disease and are taking Prednisone, which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status; Pacemaker use
11886465,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria for age, type 2 diabetes, and high cardiovascular risk, and does not have Type 1 diabetes or is pregnant/breastfeeding, but it's uncertain if they meet the bladder cancer/radiation therapy and chronic cystitis/recurrent UTI exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections; Provision of informed consent
11886465,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.9%, which is outside the required range of 7.0%-10.0%. Additionally, the patient is currently taking Insulin (Regular) for Hyperkalemia, which is an exclusion criterion.","confirmation the patient has a compatible smartphone; has the patient used a CGM in the past 90 days?; willingness to wear a CGM, use apps, modify diet/lifestyle, and attend study visits; English comprehension; Acetaminophen dosage; participation in other trials"
11886465,NCT06864546_Glutotrack,INELIGIBLE,"Patient is older than 70 (age 83), is currently using insulin, has a history of myocardial infarction and bypass surgery, is taking methylprednisolone and metoprolol, all of which exclude the patient from the study.",Duration of diabetes diagnosis; Use of electronic pacemaker; Physical activity level
18106039,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 Diabetes, and evidence of high cardiovascular risk. Patient does not meet any exclusion criteria.",
18106039,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
18106039,NCT06864546_Glutotrack,INELIGIBLE,"Patient is using insulin, HbA1c is not below 8.5%, patient is on a beta blocker, and patient may have symptomatic heart disease.",Duration of diabetes diagnosis; Physical activity level
10702075,DECLARE_TIMI58,ELIGIBLE,"The patient is 46 years old, diagnosed with Type 2 Diabetes, and there is no indication of any exclusion criteria being met.",
10702075,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.65%, which is outside the inclusion criterion range of 7.0%-10.0%.",current_medications; CGM use within 90 days; smartphone compatibility; willingness to use CGM and apps; willingness to modify diet/lifestyle; English reading ability; ability to attend study visits; allergies; skin conditions; acetaminophen/hydroxyurea use; participation in other trials
10702075,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 10.65%, which is above the inclusion criterion of HbA1c below 8.5%.",Physical activity level (minutes/week); Duration of diabetes diagnosis; Current Medications (specifically to rule out oral steroids and medications that lower heart rate)
12958898,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age, type 2 diabetes, and high cardiovascular risk inclusion criteria, and does not meet any exclusion criteria. However, informed consent status is unknown, making the eligibility uncertain.",Informed consent status
12958898,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
12958898,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently on insulin and Metoprolol, a beta blocker, violating both inclusion and exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; History of symptomatic heart disease; Use of oral steroids; Presence of Atrial fibrillation; Use of electronic pacemaker; HbA1c value
14214341,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes, and exhibits high risk for cardiovascular events. No exclusion criteria are met.",
14214341,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
14214341,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which is an exclusion criterion. Additionally, the patient is taking medications such as Metoprolol, Atenolol, Clonidine, Labetalol and Carvedilol that significantly lower heart rate, which is also an exclusion criterion.",
15534725,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and Type 2 Diabetes inclusion criteria. While several comorbidities suggest a high risk for cardiovascular events, it's not explicitly stated. Additionally, information regarding a history of bladder cancer/radiation therapy and chronic cystitis/recurrent UTIs is missing, making it uncertain if the patient meets all exclusion criteria.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections; Confirmation of high risk for cardiovascular events
15534725,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's comorbidities include ""Long term (current) use of oral hypoglycemic drugs"", which, although not explicitly listed as an exclusion criterion, indicates that the patient is likely taking a diabetes medication. The patient is also taking Acetaminophen, and while the dose isn't specified, the exclusion criteria state that the intended use of > 4g acetaminophen/day is exclusionary. Furthermore, the patient has Type 2 diabetes mellitus with diabetic chronic kidney disease, which could represent a significant comorbidity and make the patient unsuitable for participation, as determined by the Investigator.",
15534725,NCT06864546_Glutotrack,UNCERTAIN,"The patient's eligibility is uncertain due to missing information regarding physical activity levels, duration of diabetes diagnosis, and if amLODIPine or Losartan Potassium significantly lowers heart rate. The patient uses oral hypoglycemic drugs and has an HbA1c of 7.0, meeting the T2D criteria. Age also fits the criteria.",Physical activity levels (minutes/week); Duration of diabetes diagnosis; Impact of amLODIPine or Losartan Potassium on heart rate
14449762,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria.",
14449762,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. The patient's medication list includes Insulin, Insulin Human Regular, and Insulin Glargine.",
14449762,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, has high HbA1c, history of heart disease, is taking beta blockers, has atrial fibrillation, and has a pacemaker; all of which are exclusionary criteria.",Duration of diabetes diagnosis; Physical activity level
10738205,DECLARE_TIMI58,UNCERTAIN,"The patient has a diagnosis of Type 2 Diabetes, is over 40, and has high cardiovascular risk, meeting the inclusion criteria. However, the patient's comorbidities also include a diagnosis of Type 1 Diabetes. While the patient is primarily diagnosed with Type 2 diabetes, the presence of a Type 1 diabetes diagnosis, even if possibly historical or incorrect, raises uncertainty. Additionally, pregnancy/breastfeeding status is unknown.",Confirmation of diabetes type (Type 1 vs Type 2); Pregnancy/Breastfeeding status
10738205,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.","CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM; Intended acetaminophen/hydroxyurea use; Pregnancy/lactation status; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps and consistent availability; Willingness to wear CGM, use apps, and make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Investigator assessment of suitability considering comorbidities"
10738205,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to several factors: 1) They are currently using insulin, violating the inclusion criterion that requires participants to be non-insulin treated T2D patients (or only treated with metformin). 2) The patient's HbA1c is 9.58%, exceeding the inclusion criterion of HbA1c below 8.5%. 3) The patient has a history of symptomatic heart disease including myocardial infarction and coronary angioplasty/bypass, which is an exclusion criterion. 4) The patient is taking metoprolol (beta blocker), which is on the list of excluded medications.",
12385857,DECLARE_TIMI58,ELIGIBLE,"Patient is 58 years old, has Type 2 Diabetes Mellitus, and has a history of myocardial infarction indicating high risk for cardiovascular events. Patient does not meet any exclusion criteria.",
12385857,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
12385857,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which is an exclusion criterion. Also, the patient's HbA1c is 9.22%, which is above the inclusion criterion of HbA1c below 8.5%. Additionally, the patient has a history of myocardial infarction, which is an exclusion criterion.",
14375041,DECLARE_TIMI58,ELIGIBLE,"Patient meets the inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and does not have any of the listed exclusion criteria.",
14375041,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.0%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
14375041,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, has symptomatic heart disease, and takes medications that lower heart rate, violating the inclusion and exclusion criteria.",Physical activity level (minutes/week of moderate physical activity); Diabetes diagnosis date
19870285,DECLARE_TIMI58,UNCERTAIN,The patient meets the age and diabetes criteria. It is uncertain if the patient is at high risk for cardiovascular events. This information is needed to confirm eligibility.,Confirmation of high risk for cardiovascular events
19870285,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.45%, which is outside the inclusion criterion range of 7.0%-10.0%. Additionally, the patient is taking insulin, which is an exclusion criterion.",
19870285,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin, which violates the non-insulin treated T2D diagnosis inclusion criterion. The patient is also taking a medication that significantly impacts glucose metabolism (steroid) and a medication that lowers heart rate (calcium channel blocker).",Duration of diabetes diagnosis; Physical activity level; History of atrial fibrillation; Use of electronic pacemaker; Confirmation of symptomatic heart disease or lack thereof
18941401,DECLARE_TIMI58,ELIGIBLE,"Patient is 78 years old, has Type 2 Diabetes Mellitus, and likely has high risk for cardiovascular events based on comorbidities and medications. No exclusion criteria are met.",
18941401,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (as indicated by 'Insulin (Regular) for Hyperkalemia' and 'Insulin' in the current medications list), which is an exclusion criterion.",
18941401,NCT06864546_Glutotrack,INELIGIBLE,Patient is over the age limit (78 years old). The patient is an insulin user and on beta blockers (Carvedilol and Atenolol) which are exclusion criteria.,Duration of diabetes diagnosis; Presence of symptomatic heart disease; Use of oral steroids; Use of electronic pacemaker; Physical activity level
12935275,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria. High risk for cardiovascular events is likely based on comorbidities. However, information on bladder cancer/radiation therapy and chronic cystitis/recurrent UTIs is missing, which are exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
12935275,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c (13.7%) is outside the inclusion criteria (7.0%-10.0%). Also, the patient is currently taking insulin and GlipiZIDE (sulfonylureas), which is an exclusion criteria.",Has the patient used a personal CGM in the 90 days prior to consent?; Does the patient have a known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin?; Does the patient have skin conditions that are not compatible with CGM wear?; Intended use of acetaminophen/day or hydroxyurea during the study?; Current participation in another interventional clinical trial?; Does the patient have a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study?; Is the patient willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study?; Is the patient willing and able to make diet/lifestyle modifications in response to CGM data?; Is the patient able to read and understand English?; Is the patient able to attend study visits and complete the requirements of study?
12935275,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user and has an HbA1c of 13.7%, which exceeds the inclusion criterion of HbA1c below 8.5%.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker
11875731,DECLARE_TIMI58,INELIGIBLE,"The patient has a diagnosis of type 1 diabetes mellitus, which is an exclusion criteria.",
11875731,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
11875731,NCT06864546_Glutotrack,INELIGIBLE,"The patient is insulin dependent, has a history of heart disease, takes the exclusionary medication metoprolol and has atrial fibrillation.",Duration of T2D diagnosis; Use of oral steroids; Physical activity level
16066277,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria but has a urinary tract infection listed as a comorbidity. More information is needed to determine if this is chronic or recurrent. If the patient has chronic cystitis and/or recurrent urinary tract infections, they would be INELIGIBLE.",Is the patient's UTI chronic or recurrent?
16066277,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Has a personal cellular-plan or wifi-connected smartphone?; Has the patient used a personal CGM in the 90 days prior to consent?; Willing and able to wear CGM and use the associated CGM mobile apps?; Willing and able to make diet/lifestyle modifications in response to CGM data?; Able to read and understand English?; Able to attend study visits and complete the requirements of study?; Any known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin?; Skin conditions that are not compatible with CGM wear?; Intended use of > 4g acetaminophen/day or hydroxyurea during the study?; Current participation in another interventional clinical trial?
16066277,NCT06864546_Glutotrack,INELIGIBLE,The patient is ineligible due to insulin use and HbA1c level being above 8.5%.,
17636332,DECLARE_TIMI58,ELIGIBLE,"Patient is male, 62 years old, has Type 2 Diabetes, and does not meet any of the exclusion criteria. High risk for cardiovascular events can be inferred.",
17636332,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.92%, which is below the inclusion criterion of 7.0%-10.0%. The patient is also taking Insulin, which is an exclusion criteria.",CGM usage in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; History of willingness to use a smartphone CGM; Willingness to modify lifestyle
17636332,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion of being a non-insulin treated T2D patient.",
16135001,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria. However, more information is needed to determine if they meet the exclusion criteria relating to history of bladder cancer or radiation therapy and chronic cystitis/recurrent UTIs.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
16135001,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",smartphone compatibility with CGM apps; prior CGM use within 90 days; willingness to wear CGM and use apps; willingness to make diet/lifestyle modifications; ability to read and understand English; ability to attend study visits; allergy to medical grade adhesive or isopropyl alcohol; skin conditions; acetaminophen usage per day; participation in another clinical trial; suitability for participation determined by investigator
16135001,NCT06864546_Glutotrack,INELIGIBLE,"Patient uses insulin, has HbA1c above 8.5%, has a history of myocardial infarction, uses oral steroids, uses beta blockers, and has atrial fibrillation, all of which are exclusion criteria or violate inclusion criteria.",Physical activity level (minutes/week); Diabetes diagnosis date; Use of electronic pacemaker
12500183,DECLARE_TIMI58,UNCERTAIN,"Patient meets all inclusion criteria. Patient may have 'Chronic cystitis and/or recurrent urinary tract infections', which is an exclusion criteria. Patient is also missing data regarding bladder cancer history or a history of radiation therapy to the lower abdomen or pelvis.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Confirmation of recurrent urinary tract infections
12500183,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.2%, which is outside the inclusion criteria range of 7.0%-10.0%. Also, the patient is taking insulin, which is an exclusion criteria.",CGM usage within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended Acetaminophen use; Participation in another interventional clinical trial; Investigator's assessment of suitability due to comorbidities
12500183,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being 72 years old, exceeding the maximum age of 70 specified in the inclusion criteria. Also the patient is listed as an insulin user which is in the Exclusion criteria.",
12357339,DECLARE_TIMI58,ELIGIBLE,"The patient is >= 40 years old, has Type 2 Diabetes Mellitus, and has multiple risk factors for cardiovascular events. There are no explicit exclusion criteria that are definitely met.",Confirmation that the patient is not pregnant or breastfeeding; History of chronic cystitis and/or recurrent urinary tract infections
12357339,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",HbA1c level; Smartphone availability and compatibility; Prior CGM use within 90 days; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended use of acetaminophen or hydroxyurea; Pregnancy/lactation status; Participation in other interventional clinical trials; Suitability for participation based on comorbidities
12357339,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. Also, the patient is taking Atenolol and Metoprolol Tartrate, which are both beta-blockers, and also an exclusion criterion. Additionally, the patient has atrial fibrillation which is an exclusion criterion. The HbA1c value is missing, but the other factors make the patient ineligible regardless.",HbA1c
18613150,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria. Uncertainty exists regarding a history of bladder cancer/radiation therapy and chronic cystitis/recurrent UTIs, as this information is not available in the patient data.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis; Recurrent urinary tract infections
18613150,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
18613150,NCT06864546_Glutotrack,INELIGIBLE,"The patient is over the age limit, is using insulin, and is taking beta blockers, as well as having atrial fibrillation and a history of heart disease. ",Duration of diabetes diagnosis; Pregnancy status; Current use of oral steroids; Use of electronic pacemaker; Level of physical activity
14595488,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age, type 2 diabetes diagnosis, and cardiovascular risk. However, eligibility is uncertain due to the lack of information regarding a history of bladder cancer or radiation therapy to the lower abdomen or pelvis, chronic cystitis and/or recurrent urinary tract infections.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
14595488,NCT05928572_CGM_Initiation,UNCERTAIN,"The patient's HbA1c value is missing, which is a key inclusion criterion. The patient is taking multiple medications, including Hydroxyurea which is listed as an exclusion criterion if the intended use is >4g/day. The patient also has multiple comorbidities that may make them unsuitable for participation, but this would need to be determined by the investigator. It also needs to be confirmed whether any of the listed medications are anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk, which is an exclusion criterion.",HbA1c value; Intended use of Hydroxyurea; Confirmation regarding anti-hyperglycemic diabetes medications; Investigator's assessment of suitability
14595488,NCT06864546_Glutotrack,INELIGIBLE,"Patient has ischemic cardiomyopathy, atherosclerotic heart disease, coronary angioplasty, and uses amiodarone and has an implantable cardiac defibrillator, all of which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; HbA1c
15224119,DECLARE_TIMI58,UNCERTAIN,"The patient meets all inclusion criteria and does not appear to meet any exclusion criteria. However, pregnancy/breastfeeding status is unknown, which could exclude the patient.",Pregnancy status; Breastfeeding status
15224119,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
15224119,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion that the patient must be a non-insulin treated T2D patient (treated at all or only with metformin). Also, the patient uses Metoprolol, a beta blocker, which is an exclusion criterion.",
15677928,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria: age >= 40, diagnosed with Type 2 Diabetes, and High Risk for Cardiovascular events and does not meet any exclusion criteria.",
15677928,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (as indicated by 'insulin_user': true and in the current medications list), which is an exclusion criterion.",
15677928,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of ischemic heart disease, takes oral steroids and beta blockers, and has atrial fibrillation, all of which are exclusion criteria.",physical activity level; diabetes diagnosis date; pregnancy status; use of electronic pacemaker
14315792,DECLARE_TIMI58,UNCERTAIN,"While the patient meets the age and diabetes criteria, and likely meets the high risk for cardiovascular events criteria, the specific risk factors used by the trial are not stated, making it impossible to know for sure if the patient is considered 'high risk'.",Specific criteria used to define 'High Risk for Cardiovascular events' in the DECLARE-TIMI58 trial.
14315792,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.1%, which is outside the inclusion criterion range of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",
14315792,NCT06864546_Glutotrack,INELIGIBLE,"The patient is explicitly listed as an insulin user, which violates the inclusion criterion requiring non-insulin treated T2D.",
15420991,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has type 2 diabetes, and has multiple risk factors suggesting high cardiovascular risk. The patient does not meet any of the exclusion criteria.",
15420991,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion. The patient's HbA1c is missing, but since they take insulin, this doesn't affect the decision.",HbA1c
15420991,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being an insulin user, age outside the specified range, presence of a prosthetic heart valve, use of Diltiazem (a calcium channel blocker), and presence of atrial fibrillation.",Diabetes diagnosis date; Physical activity level; HbA1c; Use of an electronic pacemaker
19079053,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria. However, it is uncertain if the patient has high risk for cardiovascular events, and if their Urinary tract infection is chronic or recurrent. The informed consent status is unknown.",Confirmation of informed consent; Cardiovascular risk factors; Is the patient's Urinary tract infection chronic or recurrent?
19079053,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
19079053,NCT06864546_Glutotrack,INELIGIBLE,"The patient is older than 70, uses insulin, takes Dexamethasone, medications that lower heart rate, and has atrial fibrillation, which are all exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status; Pacemaker use; HbA1c
14637100,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria. The patient has multiple diagnoses suggesting high cardiovascular risk. However, the presence or absence of exclusion criteria (bladder cancer/radiation therapy, chronic/recurrent UTI, pregnancy/breastfeeding) cannot be determined from the data. The patient has a urinary tract infection, but it is not specified whether it is chronic or recurrent.",History of bladder cancer or radiation therapy to the lower abdomen/pelvis; Whether urinary tract infection is chronic/recurrent; Pregnancy/breastfeeding status
14637100,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, Acarbose, GlipiZIDE, GlyBURIDE and MetFORMIN which are listed as exclusion criteria.",
14637100,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to multiple factors. Firstly, the patient's HbA1c is 8.99%, which is above the inclusion criterion of below 8.5%. Secondly, the patient is using insulin, which violates the inclusion criterion of non-insulin treated T2D. Thirdly, the patient is taking Labetalol and Metoprolol, which are beta blockers, violating the exclusion criterion regarding medications that lower heart rate.",
17506585,DECLARE_TIMI58,ELIGIBLE,"Patient is male, 71 years old, has type 2 diabetes mellitus, and a history of chronic ischemic heart disease and hypertension indicating a high risk for cardiovascular events.",
17506585,NCT05928572_CGM_Initiation,UNCERTAIN,"Patient age is >18 and has a T2D diagnosis. The patient is not taking insulin, sulfonylureas, or meglitinides, and there is no indication of personal CGM use in the past 90 days. The patient is also not pregnant, lactating, or planning to become pregnant. Acetaminophen use does not exceed 4g/day. However, HbA1c is missing, making eligibility determination impossible.",HbA1c
17506585,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 71 years old, exceeding the maximum age of 70 specified in the inclusion criteria. Also, the patient has chronic ischemic heart disease, which is listed in the exclusion criteria.",
15788134,DECLARE_TIMI58,INELIGIBLE,"The patient has a comorbidity of 'Diabetes mellitus without mention of complication, type I [juvenile type], not stated as uncontrolled'. The exclusion criteria includes 'Diagnosis of Type 1 diabetes mellitus'.",
15788134,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
15788134,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being over 70 years of age, taking insulin, having symptomatic heart disease, taking medications that significantly impact glucose metabolism (oral steroids), and taking medications that significantly lower heart rate (beta blockers).",Duration of diabetes diagnosis; Physical activity level
15075290,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria and has several indicators of high cardiovascular risk. However, the patient has a current UTI and a history of UTIs, raising concerns about the exclusion criterion of chronic cystitis and/or recurrent urinary tract infections. Additionally, it is not known if informed consent has been provided.",Frequency and history of urinary tract infections/chronic cystitis; Confirmation of informed consent
15075290,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
15075290,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, history of ischemic heart disease, the use of oral steroids, the use of beta blockers, and atrial fibrillation.",Diabetes diagnosis date; Level of physical activity; Use of an electronic pacemaker
10338898,DECLARE_TIMI58,INELIGIBLE,"The patient is 39 years old, which is below the minimum age requirement of 40 years.",
10338898,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
10338898,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are 39 years old (inclusion criteria: age between 40 and 70), are an insulin user (inclusion criteria: non-insulin treated), have atrial fibrillation (exclusion criteria: Atrial fibrillation), and are using clonidine which lowers heart rate (exclusion criteria: Use of a medication that significantly lowers heart rate).",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
16603493,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High risk for cardiovascular events) and none of the exclusion criteria (no Type 1 diabetes, no bladder cancer/radiation history, no chronic cystitis/recurrent UTIs, and not pregnant/breastfeeding).",
16603493,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's current medication list includes insulin, which is an exclusion criterion.",Has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study; Has not used a personal CGM system within 90 days; Willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study; Willing and able to make diet/lifestyle modifications in response to CGM data; Able to read and understand English; Able to attend study visits and complete the requirements of study; Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin; Skin conditions that are not compatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea during the study; Current participation in another interventional clinical trial
16603493,NCT06864546_Glutotrack,INELIGIBLE,"Patient is taking insulin and has history of myocardial infarction, takes beta blockers and calcium channel blockers and has a history of Atrial Fibrillation, which all violate exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
18611138,DECLARE_TIMI58,UNCERTAIN,"The patient meets all inclusion criteria and none of the exclusion criteria mentioned in the provided data. However, information regarding a history of bladder cancer, radiation therapy to the lower abdomen/pelvis, chronic cystitis, and recurrent urinary tract infections is missing. This missing information prevents a definitive determination of eligibility.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
18611138,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion. The current medications list includes 'Insulin'.",
18611138,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently treated with insulin, has a history of myocardial infarction, and is taking beta blockers (Metoprolol), all of which are exclusion criteria.",Duration of diabetes diagnosis; Details on physical activity levels
17221586,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria. They also have several conditions suggesting high cardiovascular risk. However, it is uncertain whether the patient has chronic cystitis or recurrent urinary tract infections, a condition listed as exclusion criteria. It is assumed that the patient is not pregnant or breastfeeding, and is able to consent.",Confirmation of chronic cystitis or recurrent urinary tract infections; Pregnancy status
17221586,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient is currently taking insulin, which is an exclusion criterion.",CGM usage in the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea; Pregnancy/lactation status; Participation in other interventional clinical trials; Suitability for participation as determined by Investigator; Smartphone compatibility; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
17221586,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. Also, HbA1c is above 8.5%, making them ineligible.",
17718494,DECLARE_TIMI58,ELIGIBLE,Patient meets the age and type 2 diabetes inclusion criteria. Patient has multiple risk factors suggesting they are at high risk for cardiovascular events. None of the exclusion criteria are met.,
17718494,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 5.5%, which is not within the inclusion criteria range of 7.0%-10.0%. Also the patient is taking Insulin which is an exclusion criteria.",personal cellular-plan or wifi-connected smartphone availability; history of personal CGM use within 90 days; willingness to wear CGM and use associated apps; willingness to make diet/lifestyle modifications; ability to read and understand English; ability to attend study visits; allergy to medical grade adhesive or isopropyl alcohol; skin conditions; intended Acetaminophen usage during the study; pregnancy status; participation in other interventional clinical trials; Investigator's determination of suitability
17718494,NCT06864546_Glutotrack,INELIGIBLE,"The patient is using insulin for T2D, which is a violation of the first inclusion criteria.",Physical activity level; Duration of diabetes diagnosis; History of symptomatic heart disease; Atrial fibrillation; Use of an electronic pacemaker
17197845,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria, but information on bladder cancer/radiation therapy and chronic cystitis/UTIs is missing, making a definitive eligibility determination impossible.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
17197845,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
17197845,NCT06864546_Glutotrack,INELIGIBLE,The patient is ineligible because they are currently using insulin (violating inclusion criteria) and has a history of angina and cerebrovascular disease and uses beta-blockers (violating exclusion criteria).,Duration of diabetes diagnosis; Pregnancy status; Physical activity levels
16188531,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 Diabetes, and several cardiovascular risk factors. Exclusion criteria appear to be absent.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
16188531,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (Insulin Human Regular, Insulin), which is an exclusion criterion for the study.",
16188531,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin (violating the inclusion criteria), and is on Diltiazem and Metoprolol (violating exclusion criteria).",Diabetes diagnosis date; Pregnancy Status; Detailed Cardiac History; Physical Activity Level
16246045,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, high risk for cardiovascular events) and does not meet any exclusion criteria.",
16246045,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 11.0%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",
16246045,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to age, HbA1c, insulin use, history of TIA, use of beta blockers and clonidine, has atrial fibrillation, and use of a pacemaker.",Duration of diabetes diagnosis; Level of physical activity
12647760,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has type 2 diabetes, and several comorbidities suggest high cardiovascular risk. The patient does not have a history of type 1 diabetes, bladder cancer, radiation therapy to the lower abdomen or pelvis, or chronic cystitis/recurrent UTIs. The patient is also not pregnant or breast-feeding.",
12647760,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.5%, which is below the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",CGM usage within the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Participation in other interventional clinical trial; Suitability for participation given comorbidities
12647760,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 91 years old (exceeds age limit of 70), uses insulin, and has symptomatic heart disease (acute and chronic congestive heart failure and angina). They also use carvedilol, a beta blocker.",Physical activity level; Diabetes diagnosis date; Atrial fibrillation status; Pacemaker use
18158906,DECLARE_TIMI58,ELIGIBLE,"Patient meets inclusion criteria for age (69), Type 2 Diabetes, and likely meets criteria for high risk of cardiovascular events. No exclusion criteria are explicitly met.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
18158906,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.21%, which is below the inclusion criteria of 7.0%-10.0%. The patient is currently taking insulin, which is an exclusion criterion. Additionally, the patient is taking Hydroxyurea, which is an exclusion criterion if used > 4g/day.",Personal cellular-plan or wifi-connected smartphone compatibility with CGM apps; Prior CGM use within 90 days; Willingness and ability to wear CGM and use apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Known allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Current participation in another interventional clinical trial; Suitability for participation as determined by Investigator; Dosage of Hydroxyurea being taken
18158906,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and takes oral steroids (Prednisone) and beta blockers (Metoprolol Tartrate, Labetalol, Propranolol). All are exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Physical activity levels
19917323,DECLARE_TIMI58,ELIGIBLE,"Patient is male, 68 years old, has Type 2 Diabetes Mellitus, and has atherosclerotic heart disease, indicating a high risk for cardiovascular events. No exclusion criteria are obviously met.",
19917323,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.4%, which is below the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",smartphone ownership/access; CGM usage in past 90 days; willingness to wear CGM; willingness to modify diet/lifestyle; English literacy; ability to attend study visits; acetaminophen dosage; participation in other interventional clinical trial; allergies to adhesives or alcohol; skin conditions
19917323,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin and a beta blocker (Metoprolol Tartrate). Additionally, the patient has atherosclerotic heart disease without angina.",Duration of diabetes diagnosis; Level of physical activity; Use of an electronic pacemaker
13651995,DECLARE_TIMI58,ELIGIBLE,"Patient meets inclusion criteria for age, type 2 diabetes, and high cardiovascular risk. No exclusion criteria appear to be met based on provided data.",
13651995,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.3%, which is outside the inclusion range of 7.0%-10.0%. Also, the patient is currently taking insulin, which violates the exclusion criteria.",
13651995,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, use of Prednisone and Carvedilol, and history of symptomatic heart disease. They also have coronary angioplasty implants.",Date of diabetes diagnosis; Level of physical activity
15875182,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and does not have any listed exclusion criteria (no Type 1 Diabetes, no history of bladder cancer/radiation to lower abdomen, no mention of chronic cystitis/recurrent UTI, and not pregnant/breastfeeding).",
15875182,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Information on personal CGM use within 90 days; Information on allergies to medical grade adhesive or isopropyl alcohol; Information on skin conditions; Information on intended use of acetaminophen or hydroxyurea; Confirmation that the patient has a compatible smartphone and is willing to use it throughout the study; Assessment of willingness and ability to make diet/lifestyle modifications in response to CGM data; Assessment of ability to read and understand English; Assessment of ability to attend study visits and complete the requirements of the study; Information on current participation in another interventional clinical trial
15875182,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently treated with insulin, has a history of heart failure and atrial fibrillation, and is taking medications that significantly lower heart rate (Amiodarone, Metoprolol Tartrate).",Duration of diabetes diagnosis; Physical activity level; Use of electronic pacemaker
10354217,DECLARE_TIMI58,UNCERTAIN,"The patient meets all the inclusion criteria and does not appear to meet the exclusion criteria, except for the history of chronic cystitis and/or recurrent urinary tract infections, which is uncertain based on the available information. A urinary tract infection is listed in the patient's comorbidities, but it is not specified if it's recurrent or chronic.",Details regarding the urinary tract infection: Is it chronic or recurrent?
10354217,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.46%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
10354217,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin, which is not permitted by the inclusion criteria. The patient is also taking medications that significantly lower heart rate and has atrial fibrillation, both of which are exclusion criteria. The patient also has symptomatic heart disease, which is an exclusion criterion.",Physical activity level; Duration of diabetes diagnosis; Current pregnancy status; Use of an electronic pacemaker
10080813,DECLARE_TIMI58,UNCERTAIN,"Patient meets the inclusion criteria, but there is missing information regarding history of bladder cancer/radiation therapy to lower abdomen/pelvis and chronic cystitis/recurrent urinary tract infections, which are exclusion criteria. High CV risk is assumed due to multiple comorbidities.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
10080813,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.0%, which is outside the inclusion criterion of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Current participation in another interventional clinical trial; Personal cellular-plan or wifi-connected smartphone; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
10080813,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being 80 years old, using insulin, taking Metoprolol, having atrial fibrillation and a pacemaker.",Duration of T2D diagnosis; Physical activity level
18623464,DECLARE_TIMI58,ELIGIBLE,"The patient is a 69-year-old male with Type 2 Diabetes and multiple indicators of high cardiovascular risk, with no listed exclusion criteria.",
18623464,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 11.57%, which is outside the inclusion criteria range of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criteria.",Use of personal CGM within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea; Current participation in another interventional clinical trial; Suitability for participation as determined by Investigator; Smartphone compatibility and availability; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete the requirements of study
18623464,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 11.57%, which exceeds the inclusion criterion of HbA1c below 8.5%. Additionally, the patient uses insulin, violating the inclusion criterion of non-insulin treated T2D.",
10184623,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and has no listed exclusion criteria (no Type 1 diabetes, no bladder cancer/radiation therapy history, not pregnant/breastfeeding). Assuming informed consent is obtained and patient does not have chronic cystitis/recurrent UTIs.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections; Confirmation of informed consent
10184623,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
10184623,NCT06864546_Glutotrack,INELIGIBLE,"Patient is over 70 years old, is an insulin user, has a history of myocardial infarction, and is taking Atenolol (a beta blocker).",Date of T2D diagnosis; Pregnancy Status; Physical Activity Level
19531856,DECLARE_TIMI58,ELIGIBLE,"The patient meets all the inclusion criteria (age >= 40, Type 2 diabetes, and high risk for cardiovascular events) and does not have any of the exclusion criteria (no mention of Type 1 diabetes, bladder cancer/radiation, pregnancy/breastfeeding). Although the patient had an infection related to a catheter, there is no indication of chronic cystitis and/or recurrent urinary tract infections.",
19531856,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and glipizide (sulfonylurea), which are both exclusion criteria.",CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Intended acetaminophen dose; Current participation in another interventional clinical trial; Investigator's determination of suitability; Smartphone compatibility with CGM apps; Ability to read and understand English; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to attend study visits
19531856,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 9.95%, which is above the inclusion criterion of HbA1c below 8.5%. The patient is also listed as an insulin user, a exclusion criteria for this trial.",
18188109,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes, and has high risk for cardiovascular events. No exclusion criteria are met.",
18188109,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.0%, which is below the required range of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",CGM usage in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Current participation in another interventional clinical trial; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
18188109,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to several exclusion criteria: 1) The patient is using insulin, which excludes them from the non-insulin treated T2D diagnosis inclusion criteria. 2) The patient has atrial fibrillation, which is an exclusion criterion. 3) The patient has a history of myocardial infarction (Myocardial infarction type 2), which is an exclusion criterion. 4) The patient is taking Diltiazem and Metoprolol, both of which are medications that lower heart rate (Diltiazem is a calcium channel blocker and Metoprolol is a beta blocker), and therefore an exclusion criterion. 5) The patient is 87 years old, exceeding the maximum age of 70 set in the inclusion criteria.",
12329057,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events) and no exclusion criteria are present based on the available data.",
12329057,NCT05928572_CGM_Initiation,UNCERTAIN,"Several inclusion/exclusion criteria cannot be determined due to missing information, including HbA1c, current medications, CGM usage, smartphone compatibility, allergies, skin conditions, acetaminophen/hydroxyurea use, participation in other trials, and investigator assessment. The missing HbA1c value is especially important for this trial.","HbA1c; Current medications; CGM usage within the past 90 days; Smartphone compatibility with CGM apps; Allergies (medical grade adhesive, isopropyl alcohol); Skin conditions; Acetaminophen/hydroxyurea use; Participation in other interventional clinical trials; Ability to read and understand English; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to attend study visits and complete requirements"
12329057,NCT06864546_Glutotrack,INELIGIBLE,"The patient's age is 85, which is above the maximum age limit of 70 specified in the inclusion criteria. Also, the patient has atrial fibrillation and a history of myocardial infarction and stroke, which are exclusion criteria.",
10330196,DECLARE_TIMI58,ELIGIBLE,"Patient meets the age and Type 2 diabetes inclusion criteria, and does not appear to have any exclusion criteria based on the provided data. High risk for cardiovascular events is assumed due to age, hypertension, hyperlipidemia, diabetes and use of lisinopril and atorvastatin.",
10330196,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",HbA1c; CGM usage in the past 90 days; Smartphone compatibility and availability; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Current participation in another interventional clinical trial; Intended acetaminophen use
10330196,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently taking insulin and amLODIPine, a calcium channel blocker, both of which are exclusion criteria.",Physical activity level; Duration of diabetes diagnosis; Use of an electronic pacemaker; HbA1c
17878731,DECLARE_TIMI58,ELIGIBLE,"The patient is a 53-year-old male diagnosed with Type 2 Diabetes. His extensive comorbidity list suggests a high risk for cardiovascular events. He does not have any listed exclusion criteria such as Type 1 diabetes, bladder cancer, radiation therapy, chronic cystitis, recurrent UTIs, or pregnancy.",
17878731,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for this study.",Confirmation of CGM usage within 90 days; Information regarding allergy to medical grade adhesive or isopropyl alcohol; Presence of skin conditions incompatible with CGM wear; Dosage and frequency of Acetaminophen use; Current participation in another interventional clinical trial; Confirmation that the patient has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps; Willingness and ability to wear CGM and use the associated CGM mobile apps throughout the duration of the study; Willingness and ability to make diet/lifestyle modifications in response to CGM data; Ability to read and understand English; Ability to attend study visits and complete the requirements of the study; Investigator determination of suitability for participation given comorbidities
17878731,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently using insulin, has symptomatic heart disease, is using medications that significantly impact glucose metabolism (oral steroids), is using medications that significantly lower heart rate, and has atrial fibrillation.",Diabetes diagnosis date; Electronic pacemaker use; Physical activity level
15213332,DECLARE_TIMI58,UNCERTAIN,"The patient meets all inclusion criteria. However, the exclusion criterion regarding chronic cystitis and/or recurrent urinary tract infections cannot be definitively ruled out due to the documentation of a urinary tract infection without further specification. Therefore, eligibility is uncertain.",Confirmation whether the patient has a history of chronic cystitis and/or recurrent urinary tract infections.
15213332,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.01%, which is below the required range of 7.0%-10.0%. The patient is also currently taking insulin, which is an exclusion criterion.",CGM usage within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions compatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
15213332,NCT06864546_Glutotrack,INELIGIBLE,"The patient is over 70 years of age, uses insulin, has a history of symptomatic heart disease, takes beta blockers and has atrial fibrillation. Therefore the patient does not meet multiple eligibility criteria and meets several exclusion criteria.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker
10446230,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria and none of the exclusion criteria. The patient is over 40, has T2DM, and is at high risk for cardiovascular events. She has no history of bladder cancer, radiation to the lower abdomen, chronic cystitis or recurrent UTIs. We assume she is not pregnant or breastfeeding based on age and lack of pregnancy history.",
10446230,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
10446230,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are currently using insulin and have an HbA1c of 9.45, which is above the inclusion criterion of HbA1c below 8.5%. Additionally, the patient has a history of symptomatic heart disease including stenosis of coronary artery stent and aortocoronary bypass graft.",
10203498,DECLARE_TIMI58,UNCERTAIN,"Patient meets all inclusion criteria and none of the exclusion criteria; however, data does not confirm that patient can provide informed consent.",Confirmation of informed consent
10203498,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.79%, which is below the required range of 7.0%-10.0%. The patient is also using insulin, which is an exclusion criteria.",Smartphone compatibility; Prior CGM use; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Acetaminophen dosage; Participation in other interventional clinical trials; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Investigator opinion on suitability due to comorbidities
10203498,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being over 70 years old, being treated with insulin, having a history of symptomatic heart disease, being on heart rate lowering medications, and having atrial fibrillation.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
11592968,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria. However, they have a urinary tract infection, and it is uncertain if this is chronic or recurrent, which would be an exclusion criterion.",Whether the patient has a history of chronic cystitis or recurrent urinary tract infections.
11592968,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.4%, which is outside the inclusion criterion range of 7.0%-10.0%. The patient is also taking Insulin, which is an exclusion criterion.",
11592968,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of myocardial infarction and atrial fibrillation, and takes medications that significantly lower heart rate (Metoprolol Succinate XL, Metoprolol Tartrate, and Amiodarone), violating both inclusion and exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
19352969,DECLARE_TIMI58,ELIGIBLE,"Patient is 67 years old, has type 2 diabetes, and has multiple risk factors for cardiovascular events. There is no indication of any exclusion criteria being met.",
19352969,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is currently taking insulin and therefore does not meet inclusion criterion and does meet exclusion criterion. Patient HbA1c is missing.,HbA1c; personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps; CGM usage in the last 90 days; allergy to medical grade adhesive or isopropyl alcohol; skin conditions; acetaminophen/hydroxyurea use; participation in other interventional clinical trials
19352969,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently being treated with insulin, which violates the inclusion criteria of being non-insulin treated.",Physical activity level; Duration of diabetes diagnosis; Pregnancy status; Use of electronic pacemaker; HbA1c
13313381,DECLARE_TIMI58,INELIGIBLE,"Patient is 38 years old, which is less than the minimum age of 40 years required for the trial.",
13313381,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.14%, which exceeds the inclusion criterion of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",
13313381,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because their age (38) is outside the inclusion criteria (40-70 years), their HbA1c (10.14%) is above the inclusion criteria (below 8.5%), they are taking insulin, and they are taking amLODIPine which is a calcium channel blocker.",Physical activity level; Diabetes diagnosis date
18531371,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes inclusion criteria and does not have any of the listed exclusion criteria EXCEPT there is uncertainty regarding the 'Chronic cystitis and/or recurrent urinary tract infections' exclusion criteria. The patient has a urinary tract infection listed as a comorbidity, but it is not specified as chronic or recurrent.",Confirmation on whether the patient has chronic cystitis or recurrent urinary tract infections.
18531371,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.87%, which is outside the required range of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM; Participation in another interventional clinical trial; Ability to use smartphone and CGM apps; Willingness to modify diet/lifestyle; Ability to read and understand English; Ability to attend study visits
18531371,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being an insulin user, exceeding the age limit, and having a history of cerebral infarction.",
15255487,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes diagnosis, likely high risk for cardiovascular events given multiple comorbidities and medications such as Atorvastatin, Clopidogrel, Aspirin) and does not have any exclusion criteria (no Type 1 diabetes, no history of bladder cancer or radiation to lower abdomen/pelvis, no chronic cystitis/recurrent UTIs, not pregnant/breastfeeding).",
15255487,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.79%, which is outside the required range of 7.0%-10.0%. Additionally, the patient uses insulin, which is an exclusion criterion.",Confirmation of CGM use within the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Presence of skin conditions incompatible with CGM wear; Acetaminophen dosage; Participation in another interventional clinical trial; Investigator's assessment of suitability based on comorbidities; Confirmation patient has a compatible smartphone and willingness to use required apps; Confirmation of patient's willingness to wear CGM; Confirmation of patient's willingness to make diet/lifestyle modifications; Confirmation of patient's ability to read and understand English; Confirmation of patient's ability to attend study visits
15255487,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are an insulin user, have a history of TIA, and are currently taking oral steroids (Prednisone).",Duration of diabetes diagnosis; Pregnancy status; Quantification of physical activity level
10558865,DECLARE_TIMI58,ELIGIBLE,"The patient meets all the inclusion criteria (age >= 40, Type 2 Diabetes, presumed high risk for cardiovascular events) and none of the exclusion criteria (no Type 1 diabetes, no bladder cancer history/radiation, not pregnant/breastfeeding, no chronic cystitis or recurrent UTI)",
10558865,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and glipizide, which are listed as exclusion criteria. Glipizide is a sulfonylurea.",
10558865,NCT06864546_Glutotrack,INELIGIBLE,The patient is ineligible because they are currently using insulin and have an HbA1c above 8.5%.,
11601011,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of bladder cancer, which is an exclusion criterion.",
11601011,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for this trial.",
11601011,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which is a violation of the inclusion criteria (non-insulin treated T2D). The patient is also taking Atenolol, a beta blocker, which is an exclusion criterion.",
11569208,DECLARE_TIMI58,UNCERTAIN,"Patient meets the inclusion criteria, but the patient has an unspecified urinary tract infection, so it is uncertain if the patient has chronic cystitis and/or recurrent urinary tract infections, an exclusion criteria.",
11569208,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
11569208,NCT06864546_Glutotrack,INELIGIBLE,Patient is an insulin user (exclusion criteria) and has a history of myocardial infarction (exclusion criteria).,Diabetes diagnosis date; Physical activity level
11833586,DECLARE_TIMI58,ELIGIBLE,"The patient is male, aged 45, diagnosed with type 2 diabetes and has multiple risk factors for cardiovascular events. The patient does not appear to have any exclusion criteria.",
11833586,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
11833586,NCT06864546_Glutotrack,INELIGIBLE,The patient's HbA1c is above 8.5% and the patient is currently treated with insulin. The patient also uses medications that significantly lowers heart rate.,Date of T2D diagnosis; Physical activity level
18572725,DECLARE_TIMI58,ELIGIBLE,"The patient is 56 years old, has Type 2 Diabetes, and has Atherosclerotic heart disease and hypertension indicating high risk for cardiovascular events, and does not have any exclusion criteria present.",
18572725,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 10.4%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is currently taking insulin, which is an exclusion criterion.",
18572725,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use (inclusion), high HbA1c (inclusion), history of angina (exclusion), and beta blocker use (exclusion).",Diabetes diagnosis date; Level of physical activity; Use of an electronic pacemaker
17784757,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, High Risk for Cardiovascular events) and does not have any explicit exclusion criteria present in the provided data.",
17784757,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 5.9%, which is not within the required range of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",Smartphone compatibility; Prior CGM use within 90 days; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; English literacy; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Participation in other interventional clinical trials; Suitability for participation determined by investigator
17784757,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease, and is using medications that lower heart rate (beta blockers), which are all exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Presence of atrial fibrillation; Use of an electronic pacemaker
19886688,DECLARE_TIMI58,INELIGIBLE,"The patient is 39 years old, which does not meet the inclusion criterion of being at least 40 years of age.",
19886688,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.9%, which is below the required range of 7.0%-10.0%. Also, the patient is currently using insulin, which is an exclusion criterion.",Confirmation of stable diabetes medication regimen.; Availability of smartphone compatible with CGM apps.; Prior CGM use within 90 days.; Willingness to wear CGM and use apps.; Willingness to make diet/lifestyle modifications.; Ability to read and understand English.; Ability to attend study visits.; Allergy to medical grade adhesive or isopropyl alcohol.; Skin conditions incompatible with CGM wear.; Current participation in another interventional clinical trial.
19886688,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 39 years old, which falls outside the inclusion criterion of being between 40 and 70 years of age. Additionally, the patient's medical history includes 'Long term (current) use of insulin', which violates the inclusion criterion of 'Non-insulin treated T2D diagnosis (not treated at all or only with metformin)'.",
18956782,DECLARE_TIMI58,ELIGIBLE,The patient is a 55-year-old male with Type 2 Diabetes and several cardiovascular comorbidities indicative of high cardiovascular risk. He does not appear to meet any of the exclusion criteria.,
18956782,NCT05928572_CGM_Initiation,INELIGIBLE,The patient is currently taking insulin. Taking any form of insulin is listed as an exclusion criterion.,HbA1c; Smartphone compatibility; Prior CGM use within 90 days; Allergy to adhesives or isopropyl alcohol; Skin conditions incompatible with CGM; Current participation in another interventional clinical trial; Acetaminophen daily dose; Suitability for participation as determined by Investigator
18956782,NCT06864546_Glutotrack,INELIGIBLE,"Patient is using insulin, has a history of myocardial infarction and coronary bypass, and is taking beta blockers and antiarrhythmic drugs (Metoprolol, Amiodarone). These factors violate the non-insulin treated T2D inclusion criteria and the symptomatic heart disease and heart rate lowering medication exclusion criteria.",Diabetes diagnosis date; Physical activity level; Atrial Fibrillation status
13774759,DECLARE_TIMI58,ELIGIBLE,"The patient meets all the inclusion criteria: age >= 40, diagnosed with Type 2 Diabetes, and high risk for cardiovascular events (history of myocardial infarction, hypertension, hyperlipidemia, and other relevant conditions). The patient does not meet any exclusion criteria.",
13774759,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 11.97%, which is outside the inclusion criteria of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
13774759,NCT06864546_Glutotrack,INELIGIBLE,"Patient is on insulin therapy, which is an exclusion criterion, and HbA1c is 11.97 which is above the inclusion criterion of HbA1c below 8.5. Patient also has a history of atrial fibrillation and myocardial infarction, which are exclusion criteria.",
10534008,DECLARE_TIMI58,ELIGIBLE,"Patient is 48 years old, has Type 2 Diabetes, and has several conditions indicating high risk for cardiovascular events. No exclusion criteria are met based on the available data.",
10534008,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.2%, which is outside the inclusion range of 7.0%-10.0%. The patient is currently taking Insulin, which is an exclusion criterion.",Information regarding personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps.; Information regarding CGM use within the last 90 days.; Information regarding allergy to medical grade adhesive or isopropyl alcohol.; Information regarding skin conditions.; Information regarding intended use of acetaminophen or hydroxyurea.; Information regarding current participation in another interventional clinical trial.
10534008,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has hypertensive heart disease which may be considered a symptomatic heart disease, and uses amLODIPine which can significantly lower heart rate, thus violating the exclusion criteria.",
12542450,DECLARE_TIMI58,UNCERTAIN,"The patient appears to meet the inclusion and exclusion criteria, but the documentation of informed consent is missing. Need to confirm that informed consent was obtained prior to any study specific procedures.",Documentation of informed consent
12542450,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
12542450,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of heart failure, and takes oral steroids and beta blockers, all of which are exclusion criteria.",physical activity level; diabetes diagnosis date; use of an electronic pacemaker; HbA1c
16371036,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria (age >=40, Type 2 diabetes, high risk for cardiovascular events) and none of the exclusion criteria are apparent in the provided data.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
16371036,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.91%, which is outside the inclusion criteria of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",
16371036,NCT06864546_Glutotrack,INELIGIBLE,"The patient is being treated with insulin and other medications besides metformin, has a history of heart failure and ischemic heart disease, and is using a calcium channel blocker.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status; Use of an electronic pacemaker
14229469,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria based on age, type 2 diabetes diagnosis, and cardiovascular risk factors. Exclusion criteria of Type 1 diabetes and bladder cancer history/radiation are not met, and chronic cystitis/UTIs is not mentioned. However, pregnancy/breastfeeding status is unavailable, so cannot say for certain.",Pregnancy/breastfeeding status
14229469,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
14229469,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, has an HbA1c above 8.5%, and uses medications that significantly impact glucose metabolism and lower heart rate, violating multiple inclusion and exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
17253295,DECLARE_TIMI58,UNCERTAIN,"Patient has a urinary tract infection, which may be a sign of chronic cystitis/recurrent UTIs. Pregnancy/breast-feeding status is unknown.",Is the urinary tract infection chronic or recurrent?; Is the patient pregnant or breast-feeding?
17253295,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.36%, which falls outside the inclusion criterion of 7.0%-10.0%. The patient is also an insulin user, which is an exclusion criterion.",
17253295,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has a history of TIA/cerebral infarction, and is taking oral steroids (Prednisone, Methylprednisolone) and Amlodipine, all of which are exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Physical Activity Level
12274442,DECLARE_TIMI58,UNCERTAIN,"Patient meets all inclusion criteria and has no explicit exclusion criteria. Determination is uncertain due to potential chronic cystitis and/or recurrent urinary tract infections. Patient has comorbidity of Urinary tract infection, site not specified. It cannot be determined if it is chronic or recurrent.",Details regarding history of chronic cystitis and/or recurrent urinary tract infections
12274442,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and glyburide, which are exclusion criteria.",
12274442,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 76 years old, which is outside the inclusion criterion of age between 40 and 70. Also, the patient is explicitly listed as a current insulin user, which violates the non-insulin treated T2D diagnosis inclusion criteria, and the patient takes metoprolol, which lowers heart rate, and is therefore an exclusion criteria.",
16407305,DECLARE_TIMI58,UNCERTAIN,Uncertainty regarding history of bladder cancer/radiation therapy and recurrent UTIs.,History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of recurrent urinary tract infections
16407305,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. Also, HbA1c is missing.",CGM usage in the past 90 days; Allergy to adhesives/alcohol; Skin conditions; Acetaminophen dosage; Current participation in other clinical trials; Smartphone compatibility; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
16407305,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 87 years old, which is outside the age range of 40-70. The patient is also currently using insulin, which is an exclusion criterion.",Physical activity level
11872499,DECLARE_TIMI58,UNCERTAIN,"Uncertainty regarding chronic cystitis and/or recurrent urinary tract infections. The patient has a urinary tract infection, but it is unspecified whether it is chronic or recurrent.",History of chronic cystitis; History of recurrent urinary tract infections
11872499,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
11872499,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, is over the age limit, has symptomatic heart disease, and is taking both an oral steroid and a beta blocker, all of which are exclusionary criteria.",Physical activity level; Diabetes diagnosis date; Pregnancy status; Use of an electronic pacemaker; HbA1c
17002760,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, High Risk for Cardiovascular events) and none of the exclusion criteria (no Type 1 diabetes, no history of bladder cancer/radiation, no chronic cystitis/recurrent UTIs, not pregnant/breastfeeding).",
17002760,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 5.63%, which is outside the inclusion criteria of 7.0%-10.0%. Patient is also taking insulin, which is an exclusion criteria.",
17002760,NCT06864546_Glutotrack,INELIGIBLE,"The patient is diagnosed with T2D and uses insulin, which violates the inclusion criterion that the patient must be non-insulin treated. Also, the patient is taking Metoprolol Tartrate and Labetalol, both of which are beta blockers, violating the exclusion criterion regarding medications that significantly lower heart rate.",
18301835,DECLARE_TIMI58,UNCERTAIN,"Patient meets most inclusion criteria including age, type 2 diabetes and high risk for cardiovascular events. The patient is male so pregnancy and breastfeeding are not applicable. Patient does not have type 1 diabetes or history of bladder cancer or radiation therapy to the lower abdomen/pelvis. However, the patient's history of chronic cystitis and/or recurrent urinary tract infections is uncertain. While it is not explicitly stated in the comorbidities, Ciprofloxacin is listed under current medications, therefore, more information is needed.",History of chronic cystitis and/or recurrent urinary tract infections
18301835,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.17%, which is below the required range of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",Smartphone compatibility with required CGM apps; CGM use within the past 90 days; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications based on CGM data; English comprehension; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Participation in other interventional clinical trials; Suitability for participation based on other comorbidities
18301835,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently using insulin, oral steroids (Prednisone, MethylPREDNISolone Sodium Succ), and beta blockers (Carvedilol, Metoprolol Tartrate). The patient also has a history of symptomatic heart disease (coronary angioplasty, CABG, hypertensive heart disease with heart failure).",Duration of diabetes diagnosis; Level of physical activity
15606157,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria. They also have several risk factors suggesting they are at high risk for cardiovascular events. It is not definitively clear whether the patient has chronic cystitis/recurrent UTIs, or if they are currently pregnant or breastfeeding, making their eligibility uncertain.",History of chronic cystitis and/or recurrent urinary tract infections; Pregnancy/Breastfeeding Status
15606157,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
15606157,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently on insulin, has a history of myocardial infarction, is taking oral steroids, and is taking multiple medications that significantly lower heart rate, all of which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status
12225616,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria and is likely at high risk for cardiovascular events. There is no information to suggest any exclusion criteria are met. However, informed consent cannot be confirmed.",
12225616,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
12225616,NCT06864546_Glutotrack,INELIGIBLE,"Patient is currently treated with insulin and is over the age limit. Additionally, the patient has atrial fibrillation and is taking beta blockers.",Diabetes diagnosis date; Use of oral steroids; Use of electronic pacemaker; Physical activity level
14099518,DECLARE_TIMI58,INELIGIBLE,"Patient has a comorbidity of Type 1 diabetes mellitus, which is an exclusion criteria.",
14099518,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (as indicated by 'insulin_user': true and 'Long term (current) use of insulin' listed in comorbidities as well as 'Insulin Human Regular' and 'Insulin (Regular) for Hyperkalemia' in the current medications), which is an exclusion criterion.",
14099518,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has symptomatic heart disease, and takes Metoprolol Tartrate, all of which are exclusion criteria. Although the patient has T2DM, the use of insulin and presence of cardiac disease would rule them out for the study.",Duration of diabetes diagnosis; Level of Physical Activity
12639950,DECLARE_TIMI58,ELIGIBLE,The patient is a male aged 83 with type 2 diabetes and is at high risk for cardiovascular events. The patient does not meet any of the exclusion criteria.,
12639950,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is explicitly taking insulin, which is an exclusion criterion.",
12639950,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 83 years old, which is outside the age range of 40-70, and is treated with insulin, thus not meeting the non-insulin treated T2D criterion.",Diabetes diagnosis duration; Physical activity level; HbA1c; Information on symptomatic heart disease; Atrial fibrillation history; Use of an electronic pacemaker
14148984,DECLARE_TIMI58,ELIGIBLE,"Patient is 67 years old, diagnosed with Type 2 Diabetes Mellitus, and has several conditions indicating high cardiovascular risk. The patient does not have any of the listed exclusion criteria.",
14148984,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently using insulin, which is an exclusion criterion.",
14148984,NCT06864546_Glutotrack,INELIGIBLE,"The patient is explicitly listed as an insulin user, which violates the inclusion criterion of being non-insulin treated. Additionally, the patient has a history of myocardial infarction which violates the exclusion criterion of symptomatic heart disease.",
14960904,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and type 2 diabetes inclusion criteria, and likely meets the high risk for cardiovascular events inclusion criteria. The exclusion criteria related to bladder cancer, radiation, and pregnancy do not apply. However, it is UNCERTAIN if the patient has chronic cystitis or recurrent urinary tract infections, which would make him INELIGIBLE. Additionally, informed consent cannot be verified.",Confirmation of no history of chronic cystitis or recurrent urinary tract infections; Confirmation of informed consent
14960904,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 11.0%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",
14960904,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 78 years old, exceeding the age limit of 70. Additionally, the patient's HbA1c is 11.0%, which is above the maximum allowed value of 8.5%. The patient is also using insulin which is not allowed as per inclusion criteria.",
17155109,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and T2DM inclusion criteria, and is not explicitly excluded by the exclusion criteria. Requires confirmation of informed consent and pregnancy status.",Informed consent; Pregnancy status; Documentation of high risk for cardiovascular events
17155109,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, making them ineligible based on the exclusion criteria.",HbA1c; Smartphone Compatibility; Prior CGM Use; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; English literacy; Ability to attend study visits; Allergy to adhesive or isopropyl alcohol; Skin conditions incompatible with CGM; Pregnancy status; Current participation in another interventional clinical trial; Acetaminophen Use
17155109,NCT06864546_Glutotrack,INELIGIBLE,"The patient is using insulin, which violates the inclusion criterion of not being treated with insulin for T2D.",Physical activity level (minutes/week of moderate physical activity); Diabetes diagnosis date; HbA1c value; Details regarding Acute infarction of intestine
13951325,DECLARE_TIMI58,INELIGIBLE,"The patient is 35 years old, and the trial requires participants to be at least 40 years of age.",
13951325,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and glipizide, which are exclusion criteria for the trial.",
13951325,NCT06864546_Glutotrack,INELIGIBLE,"Patient does not meet the following inclusion criteria: age (35, requires 40-70), HbA1c (8.89, requires <8.5%), non-insulin treatment. Patient meets the following exclusion criteria: heart failure and use of oral steroids.",Diabetes diagnosis date; Pregnancy Status; Physical activity level; Pacemaker Use; Diabetes diagnosis length (less than 3 years)
17810693,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria based on age, T2DM, and multiple risk factors for cardiovascular events. However, information on bladder cancer/radiation therapy and chronic cystitis/UTIs is missing, making eligibility uncertain.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
17810693,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
17810693,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, their HbA1c is 9.07% (above the limit of 8.5%), and they are taking amLODIPine, which is a calcium channel blocker.",Duration of diabetes diagnosis; Level of physical activity
11582633,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria (age >= 40, Type 2 diabetes, high risk for cardiovascular events) and has no apparent exclusion criteria. While the patient has a UTI, this isn't specified as chronic or recurrent, so it doesn't automatically disqualify them.",
11582633,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (Insulin Regular Human (U-500) and Insulin), which is an exclusion criterion. The patient also has multiple comorbidities and medications that may preclude enrollment but this information is not required for the ultimate decision.",
11582633,NCT06864546_Glutotrack,INELIGIBLE,"The patient is explicitly listed as an 'insulin user' in current medications and has a comorbidity of 'Long term (current) use of insulin'. This violates the inclusion criterion of 'Non-insulin treated T2D diagnosis'. Also, the patient is taking CloniDINE and Metoprolol, which are explicitly listed as exclusion criteria.",
12978382,DECLARE_TIMI58,ELIGIBLE,"Patient is 53 years old, diagnosed with Type 2 Diabetes, and likely at high risk for cardiovascular events. No exclusion criteria are present.",
12978382,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.25%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also currently taking insulin and a sulfonylurea, which are exclusion criteria.",CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended acetaminophen/hydroxyurea use; Pregnancy status; Participation in other interventional clinical trials; Smartphone availability and compatibility; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
12978382,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, has an HbA1c above 8.5%, and uses beta-blockers (Labetalol and Clonidine), making them ineligible for the study.",Duration of T2D diagnosis; Physical activity level
14214341,DECLARE_TIMI58,ELIGIBLE,"The patient is male, 50 years old, diagnosed with Type 2 Diabetes, and has a high risk for cardiovascular events based on multiple comorbidities. He does not have any listed exclusion criteria.",
14214341,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
14214341,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease, and is taking oral steroids and medications that significantly lower heart rate. These factors violate the inclusion and exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
12629372,DECLARE_TIMI58,UNCERTAIN,"Patient has a current urinary tract infection, and it is unclear if this is chronic or recurrent, which is an exclusion criteria.",Information on whether the patient has a history of chronic cystitis and/or recurrent urinary tract infections
12629372,NCT05928572_CGM_Initiation,UNCERTAIN,"Patient eligibility is uncertain due to missing HbA1c value and information on current medication regimen, CGM usage, allergies, skin conditions, other medications, trial participation, and ability to comply with study requirements. The patient also has several comorbidities that need to be evaluated by the investigator.","HbA1c value; Current diabetes medication regimen; Stable dose of diabetes medication for at least 30 days; Personal CGM system use within 90 days; Smartphone compatibility with CGM apps; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication with hypoglycemia risk; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea; Current participation in another interventional clinical trial; Investigator assessment of suitability due to comorbidities"
12629372,NCT06864546_Glutotrack,UNCERTAIN,"Missing HbA1c, physical activity level, diabetes diagnosis duration, and pacemaker information. The patient's history of ""sudden cardiac arrest"" is a possible indicator of symptomatic heart disease. We do not have confirmation of Metformin use.",HbA1c; Physical activity level (minutes/week of moderate activity); Duration of diabetes diagnosis; Use of electronic pacemaker; Confirmation of Metformin use; Clarification of medication use
11652380,DECLARE_TIMI58,UNCERTAIN,"Patient meets all inclusion criteria. However, it is uncertain if the patient has a history of bladder cancer or radiation therapy to the lower abdomen or pelvis, or if the patient is taking Cephalexin for chronic cystitis or recurrent urinary tract infections. More information is needed to determine if the patient meets any exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Reason for Cephalexin prescription
11652380,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Smartphone access and compatibility with CGM apps; Prior CGM use within 90 days; Willingness to wear CGM and use apps/modify diet; Ability to read and understand English; Ability to attend study visits; Allergy to adhesive or alcohol; Skin conditions incompatible with CGM wear; Intended acetaminophen dose; Participation in other interventional trial; HbA1c value
11652380,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion that they be non-insulin treated.",
16812369,DECLARE_TIMI58,UNCERTAIN,"While the patient meets the age and Type 2 Diabetes criteria, and likely meets the high risk for cardiovascular events criteria, there is no explicit confirmation of high cardiovascular risk based solely on the available data. The presence or absence of a history of bladder cancer or radiation therapy, chronic cystitis, and ability to provide informed consent are unknown.",Confirmation of high cardiovascular risk based on specific medical history; History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis or recurrent urinary tract infections; Confirmation of patient's ability to provide informed consent
16812369,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.39%, which is outside the required range of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
16812369,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, is older than the specified age limit (78 vs. 40-70), and is currently taking oral steroids, all of which violate inclusion or exclusion criteria.","Duration of diabetes diagnosis; Level of physical activity; Details of symptomatic heart disease, if any; Impact of lisinopril on heart rate"
11292424,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria for age, Type 2 Diabetes, and high risk for cardiovascular events. The patient does not have Type 1 Diabetes. However, information regarding history of bladder cancer, radiation therapy to the lower abdomen or pelvis, chronic cystitis, and/or recurrent urinary tract infections is unavailable.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
11292424,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
11292424,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, has a history of symptomatic heart disease, is taking oral steroids, taking medications that significantly lower heart rate, and has a history of atrial flutter. These factors violate the exclusion criteria of the trial.",Duration of diabetes diagnosis; Pregnancy status; Use of an electronic pacemaker; Level of physical activity
13551085,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age, diagnosis of Type 2 Diabetes and risk factors indicating a high risk for cardiovascular events. There is nothing to suggest exclusion criteria are met. However, we need to exclude the possibility of a history of bladder cancer, radiation therapy to the lower abdomen or pelvis, and chronic cystitis/recurrent UTIs.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
13551085,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. They also do not meet the inclusion criteria regarding stable diabetes medication.",CGM usage within the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Specific skin conditions; Intended acetaminophen use during the study; Participation in other interventional clinical trials; Ability to use a smartphone and CGM apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits
13551085,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, has an HbA1c above the acceptable limit, and is taking medications that significantly lower heart rate and has a diagnosis of atrial fibrillation.",Duration of diabetes diagnosis; Level of physical activity; Use of electronic pacemaker; Confirmation if symptomatic heart disease
12290869,DECLARE_TIMI58,ELIGIBLE,"The patient is >= 40 years old, diagnosed with Type 2 Diabetes, and has high risk for cardiovascular events. The patient does not meet any of the exclusion criteria.",
12290869,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking Insulin and Glipizide, which are exclusion criteria.",
12290869,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 87 years old (exclusion - age > 70), is using insulin (exclusion - not non-insulin treated), and is taking propranolol (exclusion - beta blocker).",Diabetes diagnosis date; Physical activity level; Information on whether the embolisms and thrombosis were symptomatic
12894851,DECLARE_TIMI58,ELIGIBLE,"Patient is 64 years old, diagnosed with Type 2 Diabetes, and likely at high risk for cardiovascular events. None of the exclusion criteria appear to be met.",
12894851,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. Also, the HbA1c value is missing, making it impossible to confirm eligibility based on this inclusion criterion.",Smartphone compatibility; Prior CGM use (90 days); Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Acetaminophen dosage; Participation in another trial; Allergy to adhesive/alcohol; Skin conditions incompatible with CGM
12894851,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion that requires patients to be non-insulin treated T2D.",Physical activity level; Duration of diabetes diagnosis
16135629,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40 years old, has type 2 diabetes, and likely has high risk for cardiovascular events based on comorbidities and current medications. The patient does not have any exclusion criteria.",
16135629,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.4%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criteria.",personal cellular-plan or wifi-connected smartphone availability and compatibility; CGM usage within 90 days; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Current participation in another interventional clinical trial; Investigator's assessment of suitability based on comorbidities
16135629,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 80 years old, which is outside the age range (40-70), and uses insulin, violating the inclusion criteria. Patient also uses amLODIPine, a calcium channel blocker, which is a medication that significantly lowers heart rate, violating the exclusion criteria.",Diabetes diagnosis date; Pregnancy status; Physical activity level; Use of an electronic pacemaker
14617334,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and T2DM inclusion criteria. Multiple co-morbidities indicate high cardiovascular risk. No explicit exclusions noted, but confirmation of informed consent and chronic/recurrent UTI is required.",Confirmation of informed consent; Clarification on whether the patient's urinary tract infection is chronic or recurrent
14617334,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
14617334,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. Additionally, the patient has a history of ischemic cardiomyopathy and cerebral infarction, which are exclusion criteria related to symptomatic heart disease and ischemic cerebrovascular events.",
11845163,DECLARE_TIMI58,INELIGIBLE,"The patient is 39 years old, which is less than the minimum age of 40 years required for inclusion in the trial.",
11845163,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for this study.",
11845163,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to age (39, required 40-70), HbA1c (9.0, required <8.5), current insulin use, beta-blocker use (Metoprolol Tartrate and Labetalol), and oral steroid use (PrednisoLONE Acetate 1% Ophth. Susp.).",Physical activity level; Diabetes diagnosis date; Use of electronic pacemaker
12410201,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of bladder cancer, which is an exclusion criterion.",
12410201,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
12410201,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to being over the age limit, insulin use, history of coronary bypass, and taking beta blockers, and history of atrial fibrillation.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker; Use of medications that significantly impacts glucose metabolism (oral steroids)
13538362,DECLARE_TIMI58,INELIGIBLE,"The patient has a personal history of bladder cancer, which is an exclusion criterion.",
13538362,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion. Also taking acetaminophen and amount is unknown.",HbA1c; CGM Usage in past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Current participation in another interventional clinical trial; Ability to use a smartphone and CGM apps; Willingness to make diet/lifestyle changes; Ability to read and understand English; Ability to attend study visits
13538362,NCT06864546_Glutotrack,INELIGIBLE,The patient is ineligible due to age being over the limit (74 > 70) and current insulin use which violates the inclusion criteria of non-insulin treated T2D.,Physical activity level in minutes per week; HbA1c value; Diabetes diagnosis date
16135001,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria, likely meets high risk CV event criteria, and is male. However, we cannot determine chronic cystitis and/or recurrent urinary tract infections, and history of bladder cancer or radiation therapy to the lower abdomen or pelvis.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Confirmation regarding chronic cystitis and/or recurrent urinary tract infections
16135001,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
16135001,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because their HbA1c is 9.35%, which is above the inclusion criterion of HbA1c below 8.5%. Also, the patient is an insulin user, and one of the inclusion criteria is non-insulin treated T2D diagnosis (not treated at all or only with metformin).",
16127152,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria (age >=40, Type 2 Diabetes, High Risk for Cardiovascular events) and does not meet any exclusion criteria.",
16127152,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and GlyBURIDE, which are exclusion criteria.",
16127152,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, has an HbA1c above 8.5%, has symptomatic heart disease, and uses beta-blockers, all of which are exclusion criteria.",Duration of diabetes diagnosis; Level of physical activity; Presence of atrial fibrillation; Use of an electronic pacemaker
12201447,DECLARE_TIMI58,ELIGIBLE,"Patient is 57 years old, diagnosed with Type 2 Diabetes, and has multiple risk factors indicating high cardiovascular risk. The patient does not meet any exclusion criteria.",
12201447,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Confirmation of no CGM use within 90 days; Information on smartphone availability and compatibility with CGM apps; Confirmation of willingness to wear CGM and use associated apps; Confirmation of willingness to make diet/lifestyle modifications; Confirmation of ability to read and understand English; Confirmation of ability to attend study visits and complete requirements; Confirmation of no allergies to medical grade adhesive or isopropyl alcohol; Details on the skin condition 'Generalized skin eruption due to drugs and medicaments taken internally' and its compatibility with CGM wear; Acetaminophen dosage; Current participation in other interventional clinical trials; Investigator's assessment of suitability based on comorbidities
12201447,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, has an HbA1c of 9.4% (above the limit of 8.5%), and is taking Metoprolol (a beta blocker).",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker
10969267,DECLARE_TIMI58,UNCERTAIN,Patient meets age and T2DM criteria. No exclusion criteria are met. Determination of 'High Risk for Cardiovascular events' is required for final eligibility.,
10969267,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and glipizide, which are exclusion criteria. The patient's current medications also list sulfonylureas, which is another exclusion criterion.",
10969267,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 71 years old, exceeding the maximum age limit of 70. Also, patient is on insulin, which is an exclusion criteria.",
10955059,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 diabetes, and likely high risk for cardiovascular events based on comorbidities. No exclusion criteria appear to be met.",
10955059,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 4.5%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also currently taking insulin, which is an exclusion criterion.",
10955059,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently on insulin, which is an exclusion criteria. The patient is also taking amLODIPine, which significantly lowers heart rate, which is also an exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Use of electronic pacemaker; Physical activity level
11578301,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria for age and type 2 diabetes and appears to have high cardiovascular risk. However, the absence of information regarding a history of bladder cancer, radiation therapy to the lower abdomen or pelvis, chronic cystitis, and recurrent UTIs makes it uncertain if they meet all eligibility criteria.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections; Pregnancy or breastfeeding status
11578301,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. The patient is also taking metformin which fails the medication inclusion criteria. ",Smartphone compatibility with CGM apps; Prior CGM use within 90 days; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Acetaminophen usage amount; Current participation in another interventional trial; Skin conditions and allergies related to CGM wear
11578301,NCT06864546_Glutotrack,INELIGIBLE,"The patient does not meet the inclusion criteria because they are being treated with insulin and their HbA1c is above 8.5%. Additionally, the patient meets multiple exclusion criteria including symptomatic heart disease and the use of medications that significantly lower heart rate.",Duration of diabetes diagnosis; Level of physical activity; Pregnancy status
18560707,DECLARE_TIMI58,ELIGIBLE,"Patient is male, aged 54, diagnosed with Type 2 Diabetes, and presents with hypertension, hyperlipidemia, and diabetic peripheral angiopathy suggesting a high risk for cardiovascular events.",
18560707,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion. Also, the patient's HbA1c value is missing, so it is uncertain whether this patient satisfies the HbA1c inclusion criterion.",hba1c
18560707,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which violates the inclusion criteria. The patient also uses Atenolol, a beta blocker, which violates the exclusion criteria.",Physical activity level; Date of diabetes diagnosis; HbA1c
16142166,DECLARE_TIMI58,UNCERTAIN,The patient meets the inclusion criteria but has a history of acute cystitis and urinary tract infections. It is uncertain if this qualifies as 'chronic cystitis and/or recurrent urinary tract infections' which is an exclusion criterion.,Clarification on whether the patient's cystitis and urinary tract infections are chronic and/or recurrent.
16142166,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.73%, which falls outside the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",
16142166,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to age exceeding the limit, current use of insulin, history of myocardial infarction and coronary bypass, and the use of beta blockers.",Duration of diabetes diagnosis; Pregnancy status; Pacemaker use; Physical activity level
11128746,DECLARE_TIMI58,INELIGIBLE,"The patient is 38 years old, which is less than the minimum age requirement of 40 years.",
11128746,NCT05928572_CGM_Initiation,UNCERTAIN,"Patient's HbA1c value is missing, which is a key inclusion criterion. Patient is also taking Acetaminophen and we need to know the dosage. Furthermore, several other criteria (CGM use in 90 days, allergies, skin conditions, other trial participation, investigator assessment of comorbidities, smartphone compatibility, medication review) cannot be determined from the provided data.",HbA1c value; Diabetes medication list; Acetaminophen dosage; Smartphone compatibility; CGM use in past 90 days; Allergies; Skin conditions; Participation in other interventional trials; Investigator assessment of comorbidities
11128746,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 38 years old, which does not meet the age inclusion criterion of being between 40 and 70 years old.",Physical activity level; HbA1c value; Date of T2D diagnosis
17444088,DECLARE_TIMI58,ELIGIBLE,Patient meets the age and type 2 diabetes inclusion criteria and does not meet any of the exclusion criteria. The patient's comorbidities suggest a high risk for cardiovascular events.,
17444088,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.47%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
17444088,NCT06864546_Glutotrack,INELIGIBLE,The patient is using insulin (exclusion criteria: non-insulin treated T2D diagnosis) and Metoprolol (exclusion criteria: Use of a medication that significantly lowers heart rate (beta blockers)).,Duration of Diabetes diagnosis; Physical activity level
13718764,DECLARE_TIMI58,UNCERTAIN,"The patient has a diagnosis of 'Cystitis, unspecified without hematuria'. The exclusion criteria include chronic cystitis and/or recurrent UTIs. The information provided is not sufficient to determine if the patient's cystitis is chronic or recurrent.",Information on whether the patient has a history of chronic cystitis and/or recurrent urinary tract infections.
13718764,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 10.14%, which is above the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",Personal cellular-plan or wifi-connected smartphone compatibility with required CGM apps; Prior CGM use within 90 days; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete study requirements; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea; Current participation in another interventional clinical trial; Suitability for participation determined by investigator
13718764,NCT06864546_Glutotrack,INELIGIBLE,"Patient does not meet HbA1c inclusion criteria, has symptomatic heart disease (coronary angioplasty, MI history), atrial fibrillation, use of glucose metabolism impacting medication (oral steroids), and an electronic pacemaker.",Diabetes diagnosis date; Pregnancy status; Physical activity level
13186318,DECLARE_TIMI58,ELIGIBLE,"Patient is 58 years old, has type 2 diabetes, and likely meets the high-risk cardiovascular event criterion based on current medications and comorbidities. The patient does not appear to have any exclusion criteria.",
13186318,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.48%, which is below the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking GlipiZIDE XL, which is an anti-hyperglycemic diabetes medication that carries a known hypoglycemia risk and is therefore an exclusion criterion.",
13186318,NCT06864546_Glutotrack,UNCERTAIN,"Missing information regarding physical activity level, duration of diabetes diagnosis, and use of a pacemaker. It's uncertain if the patient meets all inclusion criteria and does not have any exclusion criteria present.",Physical activity level (minutes/week of moderate activity); Duration of diabetes diagnosis; Use of electronic pacemaker
14304320,DECLARE_TIMI58,UNCERTAIN,"While the patient meets the age and T2DM inclusion criteria, and does not appear to meet any exclusion criteria, it is uncertain if the patient is at 'High Risk for Cardiovascular events.' It is also unclear if the UTI listed is chronic or recurrent. More information is needed.",Information regarding cardiovascular risk status; Whether the urinary tract infection is chronic or recurrent
14304320,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.82%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is taking insulin, which is an exclusion criterion.",
14304320,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin, which violates the inclusion criterion of being non-insulin treated for T2D. Also, the patient is over the age limit of 70 (patient is 76).",
19178513,DECLARE_TIMI58,ELIGIBLE,"The patient is 60 years old, has Type 2 Diabetes Mellitus, and has atherosclerotic heart disease and hyperlipidemia, indicating a high risk for cardiovascular events. There are no explicit exclusion criteria present in the patient data.",
19178513,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",
19178513,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease (angina), and is taking a beta-blocker (carvedilol), all of which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Atrial fibrillation status; Pacemaker use; HbA1c value
17936641,DECLARE_TIMI58,UNCERTAIN,"The patient's eligibility is uncertain because it is unclear whether their urinary tract infection is chronic and/or recurrent, which would be an exclusion criterion.",Confirmation of whether the patient has chronic cystitis and/or recurrent urinary tract infections.
17936641,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is listed as an exclusion criteria.","Confirmation of CGM usage within 90 days; Allergies to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Confirmation of smartphone ownership and English literacy; Willingness and ability to wear CGM, use CGM apps, and make diet/lifestyle modifications; Ability to attend study visits and complete the requirements of study"
17936641,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and takes a beta blocker (Metoprolol Succinate XL), violating inclusion and exclusion criteria, respectively.",Duration of diabetes diagnosis; Pregnancy status; Use of an electronic pacemaker; Level of physical activity
19118040,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age, type 2 diabetes, and cardiovascular risk inclusion criteria, and doesn't have type 1 diabetes. However, there is no information regarding informed consent, history of bladder cancer or radiation therapy to the lower abdomen or pelvis, and chronic cystitis/recurrent UTIs.",Informed Consent Status; History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
19118040,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 5.9%, which is outside the required range of 7.0%-10.0%. The patient is also currently taking insulin, which is an exclusion criterion.",prior CGM use in the past 90 days; smartphone compatibility; willingness to wear CGM; willingness to make diet/lifestyle modifications; ability to read English; ability to attend study visits; allergies; skin conditions; acetaminophen/hydroxyurea use; pregnancy status; participation in other trials
19118040,NCT06864546_Glutotrack,INELIGIBLE,"The patient is older than the specified age limit (71 > 70), uses insulin, and has atrial fibrillation, all of which are exclusion criteria.",
16229235,DECLARE_TIMI58,ELIGIBLE,"The patient is a 58-year-old female with Type 2 Diabetes and multiple cardiovascular risk factors, meeting the inclusion criteria. There are no indications of any exclusion criteria.",
16229235,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (Insulin Human Regular, Insulin), which is an exclusion criterion: ""Currently taking or planning to take any form of insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk"". Also taking GlipiZIDE.",
16229235,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
15144601,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events) and does not meet any exclusion criteria.",
15144601,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking Insulin and Glyburide, which are explicitly listed as excluded medications.",Smartphone compatibility with CGM apps; Prior CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen/Hydroxyurea use; Participation in other interventional clinical trials; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications in response to CGM data; English comprehension; Ability to attend study visits
15144601,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 8.86%, which is above the inclusion criterion of HbA1c below 8.5%. Additionally, the patient is an insulin user, while the inclusion criteria states non-insulin treated T2D.",
16887992,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria.",
16887992,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
16887992,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin and is taking oral steroids (Prednisone), both of which are exclusion criteria.",Diabetes diagnosis date; Physical activity level; HbA1c value; Use of electronic pacemaker
11554620,DECLARE_TIMI58,ELIGIBLE,"Patient is female, 62 years old, diagnosed with Type 2 Diabetes, and has multiple comorbidities indicating a high risk for cardiovascular events. The patient meets all inclusion criteria and none of the exclusion criteria.",
11554620,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.4%, which is outside the inclusion criteria range of 7.0%-10.0%. Additionally, the patient is currently taking insulin and GlipiZIDE, which are exclusion criteria.",
11554620,NCT06864546_Glutotrack,INELIGIBLE,The patient is an insulin user which is an exclusion criterion.,
17816432,DECLARE_TIMI58,UNCERTAIN,The patient has a personal history of urinary tract infections. We need to determine if the patient has chronic cystitis or recurrent UTIs which would make them ineligible.,Confirmation on whether the patient has chronic cystitis or recurrent urinary tract infections.
17816432,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
17816432,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of coronary artery bypass graft, and is taking Carvedilol (a beta blocker).",Physical activity level (minutes/week of moderate activity); Diabetes diagnosis date; Use of an electronic pacemaker; HbA1c
11194776,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 diabetes, high risk for cardiovascular events) and none of the exclusion criteria are obviously met. However, pregnancy status needs to be confirmed.",Pregnancy status
11194776,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, as stated in the 'insulin_user': true field and the 'current_medications' list contains multiple insulin medications. This violates the exclusion criterion of 'Currently taking or planning to take any form of insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk'. Additionally, their HbA1c is 6.37, which is outside the inclusion criterion range of 7.0%-10.0%.",
11194776,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion for this trial. The patient is also taking medications that lower heart rate such as Metoprolol, Diltiazem, Amiodarone, Atenolol and Labetalol, making them ineligible. Patient EGFR is very low at 17.3 and this information may make them an inappropriate subject for this trial.",
11710336,DECLARE_TIMI58,UNCERTAIN,"While the patient meets most inclusion criteria (age, T2DM), confirmation of informed consent and assessment of cardiovascular risk is needed. Although there is history of hypertension and abnormal ECG, it's uncertain if this qualifies as 'High Risk for Cardiovascular events' as specified in the inclusion criteria. The exclusion criteria are not violated.",Confirmation of informed consent; Detailed cardiovascular risk assessment
11710336,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.82%, which does not meet the inclusion criteria (7.0%-10.0%). The patient is also taking insulin, which is an exclusion criteria.",CGM usage in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Planned acetaminophen usage (>4g/day); Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
11710336,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, violating the inclusion criteria. Also, the patient is taking Metoprolol, a medication that lowers heart rate, violating the exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
16476828,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria, but it is uncertain if the patient's Urinary tract infection is chronic or recurrent, which would exclude them from the trial.",Is the patient's urinary tract infection chronic and/or recurrent?
16476828,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.2%, which is outside the required range of 7.0%-10.0%. Also, the patient is taking insulin, which is an exclusion criterion.",
16476828,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being an insulin user, exceeding the age limit, taking beta blockers, and having symptomatic heart disease.",Duration of diabetes diagnosis; Pregnancy status; Use of electronic pacemaker
18256665,DECLARE_TIMI58,ELIGIBLE,"The patient is 70 years old, has Type 2 diabetes, and has several cardiovascular risk factors suggesting high risk, meeting the inclusion criteria. There is no indication of any exclusion criteria.",
18256665,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (Insulin Human Regular; Insulin (Regular) for Hyperkalemia; Insulin Glargine (CVICU Protocol); Insulin; Heparin Flush (10 units/ml)), which is an exclusion criterion. The patient's medical history also indicates 'Long term (current) use of insulin'.",
18256665,NCT06864546_Glutotrack,INELIGIBLE,"Patient uses insulin, has history of symptomatic heart disease, uses medications that significantly lower heart rate, and has atrial fibrillation, all of which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Pacemaker use; Pregnancy status
15108590,DECLARE_TIMI58,INELIGIBLE,"Patient is 29 years old, which does not meet the inclusion criteria of age greater than or equal to 40 years. Patient is pregnant, which is listed as an exclusion criteria.",Confirmation of chronic cystitis or recurrent urinary tract infections; Confirmation of high risk for cardiovascular events; Documentation of informed consent; History of bladder cancer or radiation therapy to the lower abdomen or pelvis
15108590,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 10.55%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
15108590,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, is outside the age range (29), HbA1c above the limit (10.55%), and is pregnant. Patient is also taking Metoprolol Tartrate, a medication that lowers heart rate, which is on the exclusion list.",Duration of diabetes diagnosis; Physical Activity Level
17493163,DECLARE_TIMI58,UNCERTAIN,"Eligibility is uncertain because information regarding informed consent, history of bladder cancer or radiation therapy, and history of chronic cystitis or recurrent UTIs is unavailable.",Informed consent; History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
17493163,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.95%, which is outside the inclusion criterion of 7.0%-10.0%. Additionally, the patient is taking insulin, which is an exclusion criterion.",
17493163,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of symptomatic heart disease (ischemic cardiomyopathy, old myocardial infarction), takes medications that significantly lower heart rate (Carvedilol, Metoprolol Tartrate, Metoprolol Succinate XL, Amiodarone), and has atrial fibrillation. The use of insulin and symptomatic heart disease violate the inclusion and exclusion criteria respectively.",Duration of diabetes diagnosis; Level of physical activity
14280440,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 diabetes, and has multiple comorbidities indicating a high risk for cardiovascular events. There are no indications that the patient meets any of the exclusion criteria.",
14280440,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 10.9%, which is outside the inclusion criterion range of 7.0%-10.0%. Also, the patient is taking Insulin, which is an exclusion criterion.",CGM usage in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended acetaminophen dosage; Pregnancy status; Participation in other interventional clinical trials; personal cellular-plan or wifi-connected smartphone
14280440,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin and beta blockers, has symptomatic heart disease, and has an HbA1c of 10.9%, exceeding the eligibility limit of 8.5%.",Duration of diabetes diagnosis; Physical activity level
16403122,DECLARE_TIMI58,ELIGIBLE,"Patient meets the inclusion criteria (age >=40, Type 2 Diabetes, High Risk for Cardiovascular events) and does not meet any exclusion criteria.",
16403122,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion for the trial.",Smartphone compatibility with CGM apps; Prior CGM use within 90 days; Willingness to use CGM and modify lifestyle; English language proficiency; Ability to attend study visits; Acetaminophen dosage; Current participation in another interventional clinical trial
16403122,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin, has an HbA1c of 8.6%, which is above the limit of 8.5%, and is taking Metoprolol Tartrate, a beta blocker.",Duration of diabetes diagnosis; Patient's physical activity level
14766871,DECLARE_TIMI58,ELIGIBLE,"Patient is 68 years old, has type 2 diabetes, and has cardiovascular risk factors. The patient does not have any exclusion criteria.",
14766871,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, glipizide, and metformin which are exclusion criteria.",
14766871,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which violates the inclusion criterion of non-insulin treated T2D.",Diabetes diagnosis date; Physical activity level; Confirmation of no pacemaker use
13109270,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, High Risk for Cardiovascular events) and none of the exclusion criteria.",
13109270,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and GlipiZIDE, and has many comorbidities.",
13109270,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking insulin, which violates the inclusion criteria, and their HbA1c is above 8.5%. Additionally, they have a history of myocardial infarction and atherosclerosis, and they are taking multiple medications that lower heart rate, which violate the exclusion criteria.",Duration of diabetes diagnosis; Patient's physical activity level
14546090,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria. They also have multiple indicators of high cardiovascular risk. However, there is missing information regarding history of bladder cancer/radiation therapy and history of chronic cystitis/recurrent UTIs, which are exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
14546090,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",HbA1c value
14546090,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of symptomatic heart disease, and uses beta blockers, all of which are exclusion criteria.",Diabetes diagnosis date; Physical activity level; HbA1c
16135001,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and T2DM inclusion criteria, and no definitive exclusion criteria are met. However, informed consent is missing, the status of UTI (chronic/recurrent) is uncertain, and the confirmation of the high risk for cardiovascular events needs further assessment.",Informed consent status; Status of Urinary Tract Infection (chronic or recurrent); Confirmation of High Risk for Cardiovascular Events
16135001,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Confirmation of CGM use within the past 90 days; Presence of allergies to medical grade adhesive or isopropyl alcohol; Presence of skin conditions incompatible with CGM wear; Intended acetaminophen use during the study; Current participation in another interventional clinical trial; Whether diabetes medication doses are stable; Whether the patient is willing to maintain diabetes medications; Whether the patient has a compatible smartphone; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
16135001,NCT06864546_Glutotrack,INELIGIBLE,The patient is ineligible because they are an insulin user and have an HbA1c above 8.5%.,
14543629,DECLARE_TIMI58,INELIGIBLE,"The patient has a diagnosis of cystitis, unspecified without hematuria. This violates the exclusion criterion of chronic cystitis and/or recurrent urinary tract infections.",
14543629,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.73%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
14543629,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which is a violation of the inclusion criteria (non-insulin treated T2D). The patient also has a history of myocardial infarction, coronary bypass, and stenting procedure, which violates the exclusion criterion of symptomatic heart disease.",
16675371,DECLARE_TIMI58,ELIGIBLE,"Patient is 51 years old, has Type 2 Diabetes, and Atherosclerotic heart disease, indicating a high risk for cardiovascular events. There are no indications of any exclusion criteria.",
16675371,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
16675371,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are an insulin user, which violates the inclusion criterion that patients should not be treated with insulin.",
16439884,DECLARE_TIMI58,ELIGIBLE,"Patient meets all the inclusion criteria: age >=40, diagnosed with Type 2 Diabetes, and has high risk for cardiovascular events (multiple cardiovascular comorbidities listed). Patient does not meet any of the exclusion criteria.",
16439884,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
16439884,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 74 years old, which is outside the inclusion criterion of age between 40 and 70. The patient is also on insulin, which is an exclusion criterion.",
17533213,DECLARE_TIMI58,ELIGIBLE,"The patient is a 62-year-old male with Type 2 Diabetes and multiple cardiovascular conditions indicative of high cardiovascular risk, and no exclusion criteria are apparent based on the provided information.",
17533213,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
17533213,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion. Also takes multiple heart rate lowering medications (Metoprolol, Carvedilol, Digoxin and Amiodarone) which is an exclusion criterion. The patient also has atrial fibrillation and has presence of automatic (implantable) cardiac defibrillator",
14844252,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 diabetes, high risk for cardiovascular events) and does not have any exclusion criteria based on the available data.",
14844252,NCT05928572_CGM_Initiation,UNCERTAIN,"Patient meets the age and T2D diagnosis inclusion criteria. However, HbA1c is missing. It is also uncertain if they are taking any diabetes medications and if they have used a CGM in the past 90 days. Therefore, the patient's eligibility is uncertain.",hba1c; current_medications; insulin_user
14844252,NCT06864546_Glutotrack,INELIGIBLE,"The patient has a history of myocardial infarction and transient ischemic attack/cerebral infarction, which are exclusion criteria.",current_medications; physical activity level; diabetes diagnosis date; hba1c
17649033,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of UTIs and also uses multiple medications for BPH, so they are likely to have chronic cystitis and/or recurrent urinary tract infections. This is an exclusion criterion.",
17649033,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.61%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
17649033,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 76 years old, exceeding the maximum age limit of 70. The patient is also listed as currently using insulin, and also has a comorbidity of 'Atrial fibrillation', both of which are listed as exclusion criteria.",
13398773,DECLARE_TIMI58,ELIGIBLE,"The patient meets all the inclusion criteria: age is >= 40, has Type 2 Diabetes Mellitus, and is at high risk for cardiovascular events based on their history of atherosclerotic heart disease, myocardial infarction, and peripheral vascular disease. They also do not have any of the listed exclusion criteria.",
13398773,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's medication list includes Insulin, which is an exclusion criterion.",
13398773,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and has a history of symptomatic heart disease (myocardial infarction and angina pectoris) and takes medications that lower heart rate (Metoprolol Tartrate, Metoprolol Succinate XL, and Metoprolol). The inclusion criteria states that patients should not be on insulin and the exclusion criteria mention symptomatic heart disease and use of medications that significantly lowers heart rate.",
13640447,DECLARE_TIMI58,ELIGIBLE,"Patient meets inclusion criteria: age >=40, type 2 diabetes, and likely high risk for cardiovascular events. No exclusion criteria are apparent in the provided data.",
13640447,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",CGM usage in the last 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps and consistent availability; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications in response to CGM data; Ability to read and understand English; Ability to attend study visits and complete the requirements of study
13640447,NCT06864546_Glutotrack,INELIGIBLE,"The patient is using insulin, has an HbA1c of 8.8% which is above the limit of 8.5%, is taking Metoprolol (a beta blocker) and has a history of Cerebral Infarction.",Duration of diabetes diagnosis; Level of physical activity
16127197,DECLARE_TIMI58,ELIGIBLE,"Patient is 64 years old, has Type 2 diabetes, and has multiple risk factors for cardiovascular events. No exclusion criteria appear to be met based on the available data.",
16127197,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and metformin, which are exclusion criteria. The trial excludes patients taking insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk. Although the patient's HbA1c (7.27%) falls within the inclusion criteria range of 7.0%-10.0%, and age is within the appropriate range, the patient's use of insulin makes them ineligible.",
16127197,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are using insulin, have a history of myocardial infarction, and are taking beta blockers. These factors violate the exclusion criteria for the trial.",Diabetes diagnosis date; Pregnancy Status; Physical activity level
15297941,DECLARE_TIMI58,INELIGIBLE,Patient is 32 years old and does not meet the age requirement of being 40 years or older.,
15297941,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.24%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also currently taking insulin, which is an exclusion criterion.",Has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps; Has not used a personal CGM system within 90 days; Willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study; Willing and able to make diet/lifestyle modifications in response to CGM data; Able to read and understand English; Able to attend study visits and complete the requirements of study; Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin; Skin conditions that are not compatible with CGM wear; Quantity of Acetaminophen used per day; Planning to become pregnant; pregnant; or lactating; Current participation in another interventional clinical trial; Investigator's determination of suitability
15297941,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being outside the specified age range, being an insulin user, the presence of symptomatic heart failure, and the use of carvedilol (a beta blocker).",Duration since diabetes diagnosis; Level of physical activity
17033835,DECLARE_TIMI58,ELIGIBLE,"Patient is over 40 years old, has type 2 diabetes, and has multiple risk factors indicating high risk for cardiovascular events. Patient does not meet any exclusion criteria.",
17033835,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
17033835,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user. This violates the inclusion criterion that patients must be non-insulin treated. Additionally, the patient has a history of symptomatic heart disease (coronary atherosclerosis, angina pectoris, presence of aortocoronary bypass graft), which violates an exclusion criterion.",
12785458,DECLARE_TIMI58,INELIGIBLE,"Patient is 37 years old, which does not meet the age requirement of >=40 years.",
12785458,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking Insulin, which is listed as an exclusion criterion.",Smartphone Compatibility; Prior CGM Use in 90 Days; Willingness to Wear CGM; Willingness to Make Diet/Lifestyle Modifications; Ability to Read and Understand English; Ability to Attend Study Visits; Allergy to Adhesive/Isopropyl Alcohol; Skin Conditions Incompatible with CGM Wear; Acetaminophen Dosage; Pregnancy/Lactation Status; Participation in Other Interventional Trial
12785458,NCT06864546_Glutotrack,INELIGIBLE,"The patient is outside the age range, has an HbA1c above the limit, is taking insulin, and is taking medications that lower heart rate. Additionally, the patient has a history of heart failure and myocardial infarction.",Duration of diabetes diagnosis; Pregnancy status; Use of electronic pacemaker; Physical activity level
16798209,DECLARE_TIMI58,ELIGIBLE,"The patient is female, aged 47 years, diagnosed with Type 2 Diabetes, and has multiple comorbidities suggesting a high risk for cardiovascular events. The patient does not have any of the exclusion criteria.",
16798209,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
16798209,NCT06864546_Glutotrack,INELIGIBLE,"The patient is diagnosed with T2D, is within the required age range, and has an HbA1c within range. However, the patient is an insulin user, which violates the inclusion criterion requiring non-insulin treated T2D.",
13835898,DECLARE_TIMI58,ELIGIBLE,"The patient is female, 62 years old, diagnosed with Type 2 Diabetes, and has multiple comorbidities indicating high cardiovascular risk. The patient does not have any listed exclusion criteria.",
13835898,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",CGM use within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended acetaminophen use; Pregnancy/lactation status; Participation in other interventional clinical trial; Ability to use smartphone and CGM apps; Willingness to make lifestyle modifications; Ability to read and understand English; Ability to attend study visits
13835898,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to several factors. First, the patient's HbA1c is 9.7%, which is above the inclusion criterion of below 8.5%. Second, the patient is on insulin ('Long term (current) use of insulin'), which violates the inclusion criterion of being non-insulin treated or only treated with metformin. Third, the patient is taking carvedilol, metoprolol tartrate and metoprolol succinate, and Clonidine, which are beta blockers or medication that lowers the heart rate and are exclusionary. Finally, the patient has a history of atrial fibrillation, an exclusion criteria.",
14302714,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and does not have any of the exclusion criteria (no Type 1 diabetes, bladder cancer/radiation history, chronic cystitis/recurrent UTI, or pregnancy/breastfeeding).",
14302714,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and GlipiZIDE, which are both listed as exclusion criteria. Also, while the patient is taking acetaminophen, it isn't clear if the amount exceeds 4g/day.",Smartphone compatibility; Prior CGM use within 90 days; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements; Allergy to adhesives or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Participation in another interventional trial
14302714,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 9.95%, which exceeds the inclusion criterion of HbA1c below 8.5%. The patient is an insulin user, violating the inclusion criteria that specifies non-insulin treated T2D.",
19916566,DECLARE_TIMI58,UNCERTAIN,Patient meets age and T2DM inclusion criteria. High cardiovascular risk is highly suspected based on comorbidities but not explicitly confirmed. Uncertainty exists regarding exclusion criteria related to bladder cancer/radiation therapy and chronic/recurrent UTIs.,History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Whether the patient's urinary tract infection is chronic or recurrent; Explicit confirmation of high cardiovascular risk
19916566,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's medication list includes insulin, Ozempic and Metformin, all of which are exclusion criteria. Additionally, the medication list contains other anti-hyperglycemic diabetes medications that carry a known hypoglycemia risk.",
19916566,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin and diltiazem, which violates the non-insulin treatment inclusion criterion and the heart rate lowering medication exclusion criterion, respectively.",Physical activity level; Diabetes diagnosis date
15461250,DECLARE_TIMI58,UNCERTAIN,Patient meets all inclusion criteria. Uncertainty exists regarding the exclusion criteria of chronic cystitis/recurrent UTI and pregnancy/breast feeding.,Confirmation of no chronic cystitis or recurrent urinary tract infections; Confirmation of not pregnant and not breast-feeding
15461250,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
15461250,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease (angina), uses oral steroids (dexamethasone), and uses beta blockers (metoprolol).",Physical activity level; Diabetes diagnosis date; Pregnancy status; Use of electronic pacemaker
10913548,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes inclusion criteria and has none of the exclusion criteria. However, determination of high risk for cardiovascular events cannot be made with the available information.",Confirmation of high risk for cardiovascular events; Pregnancy Status
10913548,NCT05928572_CGM_Initiation,UNCERTAIN,"Multiple missing data points prevent accurate eligibility determination. HbA1c value is required. Current medications and diabetes medication history are needed to assess inclusion/exclusion criteria related to stable dosing and contraindicated medications. Information regarding CGM usage, smartphone compatibility, allergies, skin conditions, pregnancy status, other trial participation, and willingness to comply with study procedures is needed. The investigator must also determine if the patient's mental health conditions and social circumstances preclude safe and reliable study participation.",HbA1c; current_medications; insulin_user; smartphone_compatibility; CGM_use_within_90_days; willingness_to_wear_CGM_and_use_apps; willingness_to_make_diet/lifestyle_modifications; ability_to_read_and_understand_English; ability_to_attend_study_visits; allergy_to_medical_grade_adhesive_or_isopropyl_alcohol; skin_conditions_incompatible_with_CGM_wear; intended_use_of_>_4g_acetaminophen/day_or_hydroxyurea; planning_to_become_pregnant/pregnant/lactating; current_participation_in_another_interventional_clinical_trial; Investigator_assessment_of_suitability_given_comorbidities
10913548,NCT06864546_Glutotrack,UNCERTAIN,"Several data points are missing, including insulin use, physical activity level, HbA1c value, duration of T2D diagnosis, current medications, and pacemaker use which are needed to fully assess eligibility.",insulin_user; physical activity level; hba1c; duration of T2D diagnosis; current_medications; pacemaker use
12248257,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria.",
12248257,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
12248257,NCT06864546_Glutotrack,INELIGIBLE,"The patient is diagnosed with T2D, is between 40 and 70 years old, and has an HbA1c below 8.5%. However, the patient is an insulin user and takes Metoprolol, which is a beta blocker, making them ineligible.",
12271405,DECLARE_TIMI58,INELIGIBLE,"The patient has a personal history of bladder cancer, which is an exclusion criterion.",
12271405,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
12271405,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being an insulin user, being over the age limit (72), using beta blockers (Metoprolol), and having atrial fibrillation and heart failure.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
19515839,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has Type 2 Diabetes, and presents with comorbidities suggestive of high cardiovascular risk, without any listed exclusion criteria.",
19515839,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
19515839,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 81 years old, which is outside the inclusion criterion of age between 40 and 70. The patient is also using insulin, which violates the inclusion criterion of being non-insulin treated.",Duration of diabetes diagnosis; Level of physical activity
13545585,DECLARE_TIMI58,ELIGIBLE,"The patient is male, aged 76, has Type 2 Diabetes, and multiple comorbidities that indicate a high risk for cardiovascular events, satisfying all inclusion criteria and not meeting any exclusion criteria.",
13545585,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (Regular), which is an exclusion criterion.",
13545585,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being insulin-treated, exceeding the age limit, having an HbA1c above 8.5%, having a history of myocardial infarction, taking oral steroids (Prednisone and Methylprednisolone), taking a beta blocker (Carvedilol), and having atrial fibrillation.",Diabetes diagnosis date; Physical activity level; Electronic pacemaker usage
10670085,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40 years old, has Type 2 Diabetes, and has multiple cardiovascular risk factors. The patient does not have Type 1 diabetes, bladder cancer, or cystitis/recurrent UTIs. The patient is not pregnant or breastfeeding.",
10670085,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
10670085,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age exceeding the inclusion criteria (age 73), insulin use and beta blocker use. They also have symptomatic heart disease, making them ineligible.",Duration of diabetes diagnosis; Pregnancy status; Level of physical activity
13299965,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has Type 2 diabetes, and has multiple cardiovascular risk factors. There is no evidence of any exclusion criteria.",
13299965,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
13299965,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 81 years old, exceeding the maximum age limit of 70. Patient is on insulin, which is an exclusion criteria.",
14195912,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes type inclusion criteria and does not have any listed exclusion criteria. However, the patient data does not explicitly confirm if the patient is at ""High Risk for Cardiovascular events"" which is required for enrollment.",Confirmation of patient's cardiovascular risk status.
14195912,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
14195912,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, violating the inclusion criteria. Also, the patient uses Dexamethasone, an oral steroid, which violates an exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status; HbA1c value
14136683,DECLARE_TIMI58,INELIGIBLE,"The patient has a diagnosis of Type 1 diabetes mellitus, which is an exclusion criterion.",
14136683,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (Insulin Lispro, Insulin Pump), which is an exclusion criterion. Also, the patient's HbA1c is missing, however the insulin use alone makes the patient ineligible.",HbA1c
14136683,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin, which violates the inclusion criteria. They also have chronic heart failure, which is an exclusion criterion.",Diabetes diagnosis date; Pregnancy status; Physical activity levels; HbA1c; Whether Topiramate is prescribed for treatment for glucose metabolism side effects; Confirmation of medications that could significantly lower heart rate
12727147,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria for age and Type 2 diabetes. However, information regarding a history of bladder cancer, radiation therapy to the lower abdomen or pelvis, chronic cystitis, and/or recurrent urinary tract infections is missing, which are exclusion criteria.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
12727147,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
12727147,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age exceeding the limit, insulin use, a history of myocardial infarction and coronary angioplasty/graft, and the use of a beta-blocker (Metoprolol Succinate XL).",Duration of diabetes diagnosis; Physical activity level; Current use of oral steroids; Atrial fibrillation status; Use of electronic pacemaker; HbA1c
16813920,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria.",
16813920,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
16813920,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion for the trial.",
19182394,DECLARE_TIMI58,UNCERTAIN,"Patient meets inclusion criteria. Uncertainty exists regarding history of bladder cancer/radiation therapy to lower abdomen or pelvis, and chronic cystitis/recurrent urinary tract infections, as this information is not explicitly stated in the patient data.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
19182394,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",hba1c
19182394,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently being treated with insulin, which violates the inclusion criterion of being non-insulin treated (or only treated with metformin).",Physical activity level (minutes/week of moderate activity); Duration of diabetes diagnosis; HbA1c value; Use of an electronic pacemaker
13602608,DECLARE_TIMI58,UNCERTAIN,Patient has a diagnosis of both Type 1 and Type 2 Diabetes Mellitus. Having Type 1 Diabetes is an exclusion criterion. This needs clarification.,
13602608,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
13602608,NCT06864546_Glutotrack,INELIGIBLE,The patient is an insulin user and has an HbA1c above 8.5%. Both of these factors render the patient ineligible.,
15355207,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria, and does not definitively meet any exclusion criteria, however the patient has a UTI and it is unclear if it is chronic or recurrent.",Confirmation if patient has chronic cystitis and/or recurrent urinary tract infections.
15355207,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.1%, which is outside the inclusion range of 7.0%-10.0%. Additionally, the patient is taking insulin and GlipiZIDE, which are excluded medications.",Use of personal CGM within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea; Current participation in another interventional clinical trial; Whether the patient has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study; Whether the patient is willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study; Whether the patient is willing and able to make diet/lifestyle modifications in response to CGM data; Whether the patient is able to read and understand English; Whether the patient is able to attend study visits and complete the requirements of study; Investigator assessment of suitability due to comorbidities
15355207,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin and glipizide, has a history of myocardial infarction and coronary bypass, uses beta-blockers (Metoprolol), and has atrial fibrillation, all of which are exclusion criteria.",Physical activity level; Duration of diabetes diagnosis; Use of an electronic pacemaker
13966667,DECLARE_TIMI58,ELIGIBLE,"The patient is female, 68 years old, diagnosed with type 2 diabetes, and has a history of cardiovascular events. There is no indication of any exclusion criteria being met.",
13966667,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.35%, which is below the inclusion criteria range of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",Personal cellular-plan or wifi-connected smartphone?; Prior CGM use in the last 90 days?; Allergy to medical grade adhesive or isopropyl alcohol?; Skin conditions?; Intended use of > 4g acetaminophen/day or hydroxyurea?; Current participation in another interventional clinical trial?; Willingness to wear CGM and use apps?; Willingness to make diet/lifestyle modifications?; Ability to read and understand English?; Ability to attend study visits?
13966667,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin and has a history of cerebral infarction, both of which are exclusion criteria.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker
18369403,DECLARE_TIMI58,ELIGIBLE,"Patient is 46 years old, has type 2 diabetes, and has multiple risk factors indicating high risk for cardiovascular events. There is no indication of any exclusion criteria.",
18369403,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 10.13%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criterion.",
18369403,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 10.13%, which exceeds the inclusion criterion of HbA1c below 8.5%. Additionally, the patient is currently treated with insulin, which violates the inclusion criterion of non-insulin treated T2D.",
12661745,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria for age and type 2 diabetes and likely has a high risk of cardiovascular events. However, it is uncertain whether the patient has chronic cystitis/recurrent UTIs. The patient data does not include information on history of bladder cancer or radiation therapy to the lower abdomen or pelvis. Additionally, confirmation of informed consent is needed.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Status of cystitis/UTIs (chronic/recurrent); Confirmation of informed consent
12661745,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion.",
12661745,NCT06864546_Glutotrack,INELIGIBLE,The patient is explicitly listed as an insulin user ('Long term (current) use of insulin'). This violates the inclusion criterion requiring non-insulin treated T2D.,
13307894,DECLARE_TIMI58,UNCERTAIN,"The patient has a diagnosis of cystitis and urinary tract infection, it is unclear whether they are chronic or recurrent, which would make the patient INELIGIBLE.",Whether the patient's cystitis and/or urinary tract infections are chronic/recurrent.
13307894,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and repaglinide (a meglitinide), which are both exclusion criteria.",
13307894,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, taking oral steroids, and taking beta blockers, which are exclusion criteria. Thus, the patient is not eligible.",Physical activity level; Diabetes diagnosis duration; Pregnancy status; Detailed cardiac history to rule out exclusion
15946806,DECLARE_TIMI58,ELIGIBLE,"Patient meets the age and T2DM inclusion criteria. While 'High Risk for Cardiovascular events' is not clearly defined, the patient's comorbidities suggest high risk. The patient does not have any of the listed exclusion criteria.",
15946806,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.83%, which is not within the inclusion range of 7.0-10.0%. The patient is also currently taking insulin, which is an exclusion criteria.",Confirmation of compatible smartphone and consistent access; Confirmation of CGM usage within 90 days; Patient's willingness to wear CGM and use apps; Patient's willingness to make diet/lifestyle modifications; Patient's willingness and ability to attend study visits; Patient's ability to read and understand English; Dosage of Acetaminophen; Current participation in another interventional clinical trial; Allergies to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear
15946806,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, is taking Nadolol (a beta blocker), and MethylPREDNISolone Sodium Succ (an oral steroid). Insulin use violates the inclusion criteria and Nadolol and MethylPREDNISolone Sodium Succ use violates the exclusion criteria.",Duration of diabetes diagnosis; Level of Physical Activity
15467139,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria. However, there is no information regarding a history of bladder cancer or radiation therapy to the lower abdomen/pelvis. The patient also has a urinary tract infection, but it is uncertain whether this is a chronic cystitis and/or recurrent urinary tract infection, resulting in an uncertain eligibility.",History of bladder cancer or radiation therapy to the lower abdomen/pelvis; Whether the patient has chronic cystitis and/or recurrent urinary tract infections
15467139,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently using insulin, which is an exclusion criterion.",Whether the patient is willing to maintain stable dose diabetes medication regimen; Smartphone availability and compatibility with CGM apps; Personal CGM use within the past 90 days; Willingness and ability to wear CGM and use apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended acetaminophen or hydroxyurea use during the study; Current participation in another interventional trial
15467139,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are 83 years old (inclusion criteria: age between 40 and 70), are an insulin user (inclusion criteria: non-insulin treated T2D) and have atrial fibrillation (exclusion criteria).",
19583369,DECLARE_TIMI58,UNCERTAIN,"Patient has a Urinary tract infection, site not specified. Further clarification needed to determine if it is chronic or recurrent which is an exclusion criterion.",
19583369,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking Insulin and GlipiZIDE (a sulfonylurea), and Hydroxyurea which are exclusion criteria.",Information on stable dose of diabetes medications.; Use of CGM system within 90 days; Access to compatible smartphone with cellular plan or WiFi; Willingness to wear CGM and use apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Pregnancy status; Participation in other interventional clinical trials
19583369,NCT06864546_Glutotrack,INELIGIBLE,"Patient is older than the age limit, is taking insulin and other non-metformin diabetes medication, has symptomatic heart disease, takes oral steroids, takes heart rate lowering medication, and has atrial fibrillation.",Diabetes diagnosis date; Physical activity level; Use of electronic pacemaker
10604703,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular Events) and none of the exclusion criteria are definitively met. Although patient has E.Coli infection, this doesn't confirm chronic cystitis or recurrent UTIs.",Confirmation of absence of chronic cystitis and recurrent urinary tract infections.; Details on the E. Coli infection to assess if it represents a chronic or recurrent UTI issue.
10604703,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin and glipizide, which are explicitly listed as exclusion criteria.",Smartphone compatibility; CGM use in the past 90 days; Allergy to medical grade adhesive/isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen/Hydroxyurea Use; Participation in other interventional trial; Suitability for participation based on comorbidities (investigator determination)
10604703,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, has a history of symptomatic heart disease, takes dexamethasone, takes multiple heart rate lowering medications, and has a history of atrial fibrillation, all of which violate inclusion or exclusion criteria.",Duration of diabetes diagnosis; Level of physical activity; Use of electronic pacemaker
16645305,DECLARE_TIMI58,ELIGIBLE,"The patient meets all inclusion criteria: age >= 40, diagnosed with Type 2 Diabetes, and high risk for cardiovascular events. The patient also does not have any exclusion criteria based on provided data.",
16645305,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion and disqualifies the patient from being eligible.",HbA1c value; Information about smartphone usage and CGM experience; Information about willingness to use CGM and make diet/lifestyle changes; Ability to read and understand English; Ability to attend study visits; Personal CGM use within the last 90 days; Known allergies to medical grade adhesive or isopropyl alcohol; Skin conditions; Intended Acetaminophen or Hydroxyurea usage; Current participation in another interventional clinical trial; Suitability for participation based on comorbidities
16645305,NCT06864546_Glutotrack,INELIGIBLE,"The patient is explicitly listed as an insulin user, which is a violation of the inclusion criterion that states 'Non-insulin treated T2D diagnosis'. Also, the patient has a history of myocardial infarction, which is an exclusion criterion.",physical activity level; diabetes diagnosis date; HbA1c value
13881083,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age, T2DM diagnosis, and high risk for cardiovascular events. The patient is male so he does not meet the pregnancy exclusion criteria, and is diagnosed with T2DM so he does not meet the T1DM exclusion criteria. However, information on bladder cancer/radiation therapy and chronic cystitis/UTIs is missing.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections
13881083,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",CGM usage within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended acetaminophen or hydroxyurea use; Participation in other interventional clinical trials; Smartphone compatibility and availability; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
13881083,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to being over the age limit, insulin use, existing heart conditions, use of beta-blockers/antiarrhythmics, and having atrial fibrillation.",Duration of diabetes diagnosis; Physical activity level; Use of electronic pacemaker
14253503,DECLARE_TIMI58,ELIGIBLE,"The patient meets all the inclusion criteria: age >= 40, diagnosis of Type 2 Diabetes, and presence of cardiovascular risk factors (hypertension, hyperlipidemia, history of TIA, aortic stenosis, and chronic kidney disease). The patient does not meet any exclusion criteria.",
14253503,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
14253503,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, exceeds the age limit, has a history of TIA/cerebral infarction, and uses Nicardipine.",Diabetes diagnosis date; Physical activity level; Use of pacemaker
11144164,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age, diagnosis of Type 2 Diabetes, and high cardiovascular risk. However, the patient's history of bladder cancer/radiation therapy, chronic cystitis/UTIs, and pregnancy status are unknown, which are exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections; Pregnancy status
11144164,NCT05928572_CGM_Initiation,INELIGIBLE,The patient's HbA1c is 6.74% which is not within the inclusion criteria range of 7.0-10.0%. The patient is also taking insulin which is an exclusion criteria.,"Has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study; Has used a personal CGM system within 90 days; Willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study; Willing and able to make diet/lifestyle modifications in response to CGM data; Able to read and understand English; Able to attend study visits and complete the requirements of study; Has used a personal CGM in the 90 days prior to consent; Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin; Skin conditions that are not compatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea during the study; Planning to become pregnant; pregnant; or lactating; Current participation in another interventional clinical trial; Unsuitable for participation due to any other cause, including but not limited to significant comorbidities, as determined by Investigator"
11144164,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion of being non-insulin treated.",
14116888,DECLARE_TIMI58,UNCERTAIN,"While the patient meets the age, diabetes type, and cardiovascular risk inclusion criteria, and does not appear to have any of the explicit exclusion criteria, we lack confirmation of informed consent and sufficient information about the patient's history of urinary tract infections (UTIs) to definitively rule out chronic cystitis or recurrent UTIs. The inclusion criteria of provision of informed consent cannot be verified based on the given patient data.",Informed consent confirmation; Details regarding the history of urinary tract infections (specifically if chronic or recurrent)
14116888,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
14116888,NCT06864546_Glutotrack,INELIGIBLE,"Patient is over 70, using insulin, has a history of heart disease (myocardial infarction, ischemic cardiomyopathy, angina), takes medications that lower heart rate (beta blockers), takes oral steroids, and has atrial fibrillation.",Duration of diabetes diagnosis; Pregnancy status; Pacemaker use; Physical activity level
11845163,DECLARE_TIMI58,INELIGIBLE,"Patient is 39 years old, and the inclusion criteria requires an age of 40 years or older.",Confirmation of high risk for cardiovascular events; History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections; Confirmation of Informed Consent
11845163,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (Regular and GlipiZIDE XL), which is an exclusion criterion.",
11845163,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, age outside the specified range (39 vs. 40-70), HbA1c above the threshold (9.0% vs. <8.5%), use of oral steroids (PrednisoLONE Acetate), and use of beta blockers (Metoprolol and Labetalol).",Duration of diabetes diagnosis; Physical activity level; History of symptomatic heart disease details; Use of electronic pacemaker
11051429,DECLARE_TIMI58,ELIGIBLE,"Patient meets all the inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events based on comorbidities such as coronary atherosclerosis, heart failure, peripheral vascular disease, and stroke history) and does not meet any exclusion criteria (no Type 1 diabetes, no bladder cancer history, no radiation therapy to lower abdomen or pelvis, no chronic cystitis or recurrent UTIs, and not pregnant/breastfeeding).",
11051429,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
11051429,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user, outside the age range (74), HbA1c is 8.67%, history of symptomatic heart disease, taking beta blockers, has atrial fibrillation, and has a pacemaker.",Diabetes diagnosis date; Physical activity level
19718027,DECLARE_TIMI58,ELIGIBLE,"The patient is a 73-year-old male with Type 2 Diabetes and multiple cardiovascular risk factors, meeting all inclusion criteria and none of the exclusion criteria.",
19718027,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",Has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps?; Has used a personal CGM system within 90 days?; Willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study?; Willing and able to make diet/lifestyle modifications in response to CGM data?; Able to read and understand English?; Able to attend study visits and complete the requirements of study?; Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin?; Skin conditions that are not compatible with CGM wear?; Intended use of > 4g acetaminophen/day or hydroxyurea during the study?; Current participation in another interventional clinical trial?; Suitability for participation determined by Investigator
19718027,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age being outside the required range, use of insulin, HbA1c equal to 8.5%, a history of myocardial infarction and atrial fibrillation, and use of beta-blockers.",Duration of diabetes diagnosis; Use of electronic pacemaker; Level of physical activity
15415949,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and Type 2 Diabetes criteria. The patient has a history of myocardial infarction and heart failure, suggesting high cardiovascular risk. However, it is uncertain if the patient has a history of bladder cancer/radiation therapy to the lower abdomen or pelvis, chronic cystitis/recurrent UTIs or is pregnant.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections; Pregnancy status; Informed consent status
15415949,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and glipizide, which are explicitly listed in the exclusion criteria as medications that carry a known hypoglycemia risk.",
15415949,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to the following reasons: 1) Age is 75, which is outside the inclusion criteria of 40-70 years. 2) The patient is currently treated with insulin, which violates the inclusion criteria specifying non-insulin treated T2D. 3) Patient has a history of myocardial infarction type 2 and transient ischemic attack (TIA), which are exclusion criteria related to symptomatic heart disease.",
14276038,DECLARE_TIMI58,UNCERTAIN,"The patient's history of UTIs requires further clarification to determine if they meet the exclusion criterion for chronic cystitis and/or recurrent urinary tract infections. Also, there is no information regarding pregnancy or breastfeeding, even though the patient is female.",Confirmation regarding chronic cystitis and/or recurrent urinary tract infections; Pregnancy status; Breastfeeding status
14276038,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin (as indicated by 'insulin_user': true and 'Long term (current) use of insulin' in the comorbidities), which is an exclusion criterion.",
14276038,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which is an exclusion criterion for the trial. Also, the patient is on Metoprolol which is a beta blocker, also an exclusion criteria.",
11670720,DECLARE_TIMI58,ELIGIBLE,"The patient is a 60-year-old male with type 2 diabetes, satisfying the age and diabetes inclusion criteria. Based on the provided comorbidities, the patient is at high risk for cardiovascular events as they have atherosclerotic heart disease. The exclusion criteria related to cancer, radiation, and pregnancy do not apply to this patient. There is no indication of Type 1 diabetes.",
11670720,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.1%, which falls outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
11670720,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, which is a contraindication for the trial. Also, the patient is taking Prednisone (oral steroid), Amiodarone, Diltiazem, Metoprolol Succinate XL, and Labetalol which affect glucose metabolism and heart rate, as well as the diagnosis of paroxysmal and unspecified atrial fibrillation, which are all exclusion criteria.",Physical activity level; Diabetes diagnosis date; Use of an electronic pacemaker
18101660,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and T2DM criteria and appears to be high risk for cardiovascular events. However, the absence of a history of bladder cancer/radiation to lower abdomen/pelvis and chronic cystitis/recurrent UTIs needs to be confirmed to rule out exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
18101660,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
18101660,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age (79 years old) and current insulin use. Additionally, the patient has a history of 'Other acute and subacute forms of ischemic heart disease, other', which indicates symptomatic heart disease, an exclusion criterion.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
11754518,DECLARE_TIMI58,ELIGIBLE,"Patient is 58 years old, has Type 2 diabetes, and likely has high risk for cardiovascular events given hyperlipidemia, abnormal heart imaging, hypercholesterolemia, and obesity. Patient does not meet exclusion criteria.",
11754518,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.85%, which is outside the inclusion criterion of 7.0%-10.0%.",
11754518,NCT06864546_Glutotrack,UNCERTAIN,"Patient's eligibility is uncertain due to missing information regarding physical activity level, date of diabetes diagnosis, and clarification on the abnormal findings on diagnostic imaging of heart and coronary circulation. The latter could signify symptomatic heart disease.",Physical activity level (minutes/week of moderate activity); Date of diabetes diagnosis; Details regarding abnormal findings on diagnostic imaging of heart and coronary circulation
17218683,DECLARE_TIMI58,UNCERTAIN,"Patient meets the inclusion criteria. However, there is not enough information available to determine if the patient has a history of bladder cancer or radiation therapy to the lower abdomen/pelvis, or if they have chronic cystitis and/or recurrent urinary tract infections. These are exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen/pelvis; History of chronic cystitis and/or recurrent urinary tract infections
17218683,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient is currently taking insulin, which is an exclusion criterion.",CGM usage in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Pregnancy/lactation status; Participation in other interventional clinical trials; Investigator assessment of suitability due to comorbidities; Smartphone compatibility and consistent availability; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
17218683,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to several exclusion criteria. First, the patient's age is 88, exceeding the maximum age of 70. Second, the patient's medication list includes Insulin, meaning they are being treated with insulin, which violates the inclusion criterion of being non-insulin treated. Third, the patient's medication list includes Metoprolol Succinate XL and Metoprolol Tartrate, which are beta blockers and therefore exclusionary.",
16296020,DECLARE_TIMI58,ELIGIBLE,"The patient is 79 years old, diagnosed with Type 2 Diabetes, and has a history of cerebrovascular disease, hyperlipidemia, hypertensive chronic kidney disease, occlusion and stenosis of bilateral carotid arteries, and a personal history of TIA and cerebral infarction indicating high risk for cardiovascular events. The patient has no listed exclusion criteria.",
16296020,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.6%, which is outside the inclusion criterion of 7.0%-10.0%. The patient is taking insulin, which is an exclusion criterion.",
16296020,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to age being above the limit (79 > 70), taking insulin and glipizide, and using medications that significantly lower heart rate (beta blockers Metoprolol and Labetalol), and a history of transient ischemic attack.",Physical activity level; Diabetes diagnosis date; Pregnancy status; Use of electronic pacemaker
16899163,DECLARE_TIMI58,ELIGIBLE,"Patient is 66 years old, has Type 2 Diabetes, is at high risk for cardiovascular events (history of NSTEMI, hypertension, TIA, and cerebral infarction), and does not have any listed exclusion criteria.",
16899163,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.5%, which is outside the inclusion criteria range of 7.0%-10.0%. The patient is also currently taking insulin, which is an exclusion criterion.",Smartphone compatibility with CGM apps; CGM usage in the past 90 days; Willingness to wear CGM; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Acetaminophen dosage; Current participation in another interventional clinical trial; Known allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear
16899163,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which violates the inclusion criterion of being non-insulin treated. Additionally, the patient has a history of myocardial infarction and is on labetalol, both of which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level; Use of an electronic pacemaker
12440753,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, and high risk for cardiovascular events) and does not appear to meet any exclusion criteria.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
12440753,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
12440753,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently being treated with insulin and has heart disease and is on nadolol, which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
10174118,DECLARE_TIMI58,INELIGIBLE,"The patient takes medications which suggests chronic cystitis and/or recurrent urinary tract infections, which is listed as an exclusion criteria.",
10174118,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
10174118,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 72 years old (exceeds age limit of 70), and takes insulin, making them ineligible based on inclusion criteria. Also, patient takes amLODIPine (calcium channel blocker) listed in exclusion criteria.",Duration of diabetes diagnosis; Level of physical activity
15642594,DECLARE_TIMI58,ELIGIBLE,"The patient is male, 62 years old, has Type 2 diabetes mellitus, and has multiple cardiovascular risk factors, meeting the inclusion criteria. The patient has no listed exclusion criteria.",
15642594,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Has patient used a personal CGM in the 90 days prior to consent?; Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin?; Skin conditions that are not compatible with CGM wear?; Intended use of > 4g acetaminophen/day during the study?; Current participation in another interventional clinical trial?; Does patient have a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study?; Is patient willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study?; Is patient willing and able to make diet/lifestyle modifications in response to CGM data?; Is patient able to read and understand English?; Is patient able to attend study visits and complete the requirements of study?
15642594,NCT06864546_Glutotrack,INELIGIBLE,The patient is currently using insulin and has a history of heart failure and atrial fibrillation. The patient is also using beta blockers.,Diabetes diagnosis date; Physical activity level; Use of an electronic pacemaker
18059948,DECLARE_TIMI58,ELIGIBLE,"Patient is a 66-year-old female with Type 2 diabetes and evidence of high cardiovascular risk. There are no apparent exclusion criteria met, and the patient meets the inclusion criteria.",
18059948,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
18059948,NCT06864546_Glutotrack,INELIGIBLE,"The patient uses insulin and beta blockers, which are exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Level of physical activity
15788134,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria, and likely meets the high cardiovascular risk criteria. However, the patient's history of bladder cancer/radiation therapy and chronic/recurrent urinary tract infections is unknown, so cannot be confirmed. ",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
15788134,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
15788134,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being 73 years old (age > 70), use of insulin, symptomatic heart disease, and use of medications that impact glucose metabolism and heart rate.",Time since diabetes diagnosis; Pregnancy status; Atrial fibrillation status; Use of electronic pacemaker
12978397,DECLARE_TIMI58,UNCERTAIN,"The patient's comorbities list both Type 1 and Type 2 diabetes diagnoses, which is contradictory to the exclusion criteria regarding Type 1 diabetes. The patient is ELIGIBLE if they do NOT have Type 1 diabetes.",Confirmation of whether the patient has a history of Type 1 diabetes mellitus.
12978397,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (Tresiba), which is an exclusion criterion.",
12978397,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin (Tresiba FlexTouch U-100 and Insulin), which is a violation of the inclusion criterion requiring non-insulin treated T2D. The patient also has type 1 diabetes mellitus listed in the comorbidities.",
16856235,DECLARE_TIMI58,INELIGIBLE,"Patient has a personal history of malignant neoplasm of bladder, which is an exclusion criterion.",
16856235,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and repaglinide, which are both exclusion criteria. Additionally, the patient's HbA1c is missing.",HbA1c
16856235,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criteria that specifies non-insulin treated T2D.",
12525991,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age, diagnosis of Type 2 diabetes, and presence of multiple cardiovascular risk factors. However, it is uncertain whether the patient has chronic cystitis and/or recurrent urinary tract infections which would exclude them from the trial.",History of chronic cystitis and/or recurrent urinary tract infections
12525991,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.74%, which is outside the required range of 7.0%-10.0%. Additionally, the patient is taking Glyburide and Insulin Human Regular, which are exclusion criteria.",CGM usage within the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Intended acetaminophen use; Current participation in another interventional clinical trial; Smartphone compatibility with CGM apps and consistent availability; Willingness and ability to wear CGM and use associated mobile apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete the requirements of study; Investigator's assessment of comorbidities
12525991,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the first inclusion criterion (Non-insulin treated T2D diagnosis). Additionally, the patient is taking Amiodarone and Digoxin, both of which are medications that lower heart rate, violating an exclusion criterion.",
14641484,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of bladder cancer, which is an exclusion criterion.",
14641484,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.5%, which does not meet the inclusion criteria of 7.0%-10.0%. Also, the patient is taking insulin, which is an exclusion criterion.",Smartphone availability and compatibility with CGM apps; Prior CGM use within 90 days; Willingness and ability to use CGM and make lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical-grade adhesive or isopropyl alcohol; Skin conditions that are not compatible with CGM wear; Acetaminophen Dosage; Current participation in another interventional clinical trial; Investigator's determination of suitability
14641484,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being an insulin user, being older than 70, having a history of cerebral infarction (exclusion criteria), and taking Diltiazem (a calcium channel blocker, which is an exclusion criteria).",Duration of diabetes diagnosis; Physical activity level; Use of oral steroids; Use of electronic pacemaker
14731346,DECLARE_TIMI58,UNCERTAIN,"The patient has a history of urinary tract infections which raises concern for recurrent urinary tract infections or chronic cystitis, a potential exclusion criterion.",Details regarding the frequency and nature of the patient's urinary tract infections to rule out chronic cystitis and/or recurrent urinary tract infections.; Confirmation that the patient is not pregnant or breastfeeding.
14731346,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
14731346,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible because they are currently using insulin, which violates the inclusion criterion of non-insulin treated T2D.",
15798128,DECLARE_TIMI58,UNCERTAIN,"The patient has a history of urinary tract infections, and it is unclear if they were recurring or chronic. The patient also has urinary symptoms that could point to chronic UTIs.",Whether the patient has a history of chronic or recurrent urinary tract infections.
15798128,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and Acetaminophen. The use of insulin excludes them because they are taking insulin and the acetaminophen use exceeds 4g/day, violating exclusion criteria.",Smartphone compatibility; Recent CGM usage (past 90 days); Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Participation in another interventional clinical trial; suitability due to comorbidities
15798128,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, over the age limit (83), and has symptomatic heart failure and uses amLODIPine, all of which are exclusion criteria. These factors make the patient ineligible.",Duration of diabetes diagnosis; Physical activity level; Pregnancy status
18366478,DECLARE_TIMI58,INELIGIBLE,"The patient has a comorbidity of chronic cystitis and urinary tract infection, which is an exclusion criterion.",
18366478,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
18366478,NCT06864546_Glutotrack,INELIGIBLE,"Patient is explicitly listed as an insulin user, which violates the first inclusion criterion (non-insulin treated T2D). Additionally, the patient is currently using a systemic steroid (Prednisone), which is an exclusion criterion.",
12965924,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events, based on comorbidities such as chronic heart failure, hypertension, hyperlipidemia, and chronic kidney disease) and none of the exclusion criteria.",
12965924,NCT05928572_CGM_Initiation,UNCERTAIN,"The patient's current medications include Insulin. The patient is potentially ineligible, as they are currently taking insulin, however, per the inclusion criteria, the patient must either be taking no diabetes medication or taking stable-dose diabetes medication(s). Additionally, the patient's current medications include Acetaminophen, and it is not specified how much Acetaminophen the patient is taking. Numerous other pieces of information are missing.",Stable dose and duration of current medications; Confirmation of cellular-plan/wifi-connected smartphone compatibility; CGM use in the past 90 days; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions compatible with CGM wear; Acetaminophen usage > 4g/day or hydroxyurea use; Pregnancy status; Participation in other interventional clinical trials; Other conditions that may make patient unsuitable
12965924,NCT06864546_Glutotrack,INELIGIBLE,"Patient has chronic heart failure, uses oral steroids (Dexamethasone and Hydrocortisone), and medications that significantly lower heart rate (Metoprolol and Verapamil), all of which are exclusion criteria.",Duration of diabetes diagnosis; Physical activity levels
17210427,DECLARE_TIMI58,UNCERTAIN,"Uncertain due to lack of information regarding informed consent, high risk for cardiovascular events, and pregnancy/breastfeeding status.",Informed consent status; Confirmation of high risk for cardiovascular events; Pregnancy/Breastfeeding status
17210427,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.61%, which is below the inclusion criteria of 7.0%-10.0%. The patient is also taking insulin, which is an exclusion criteria.",
17210427,NCT06864546_Glutotrack,INELIGIBLE,"Patient is an insulin user and is on oral steroids, which violates both inclusion and exclusion criteria respectively.",Physical activity level; Diabetes diagnosis duration; Pregnancy Status; Use of pacemaker
12119595,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >=40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria (no Type 1 diabetes, bladder cancer history, radiation therapy to lower abdomen, chronic cystitis/UTIs, pregnancy/breastfeeding).",
12119595,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
12119595,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is 8.55%, which exceeds the inclusion criterion of HbA1c below 8.5%. Additionally, the patient is an insulin user, which violates the inclusion criteria. The patient has a history of heart disease (old myocardial infarction) and uses metoprolol, which are exclusion criteria.",
17163115,DECLARE_TIMI58,INELIGIBLE,"Patient is 37 years old, which is below the minimum age requirement of 40.",History of bladder cancer or radiation therapy to the lower abdomen/pelvis; Pregnancy/breastfeeding status; Assessment of Cardiovascular risk based on comorbidities and medications; Information if urinary tract infection is chronic or recurrent
17163115,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which violates the exclusion criterion regarding insulin use.",smartphone_compatibility; cgm_use_past_90_days; willingness_to_wear_cgm_and_use_apps; willingness_to_modify_diet_lifestyle; english_comprehension; ability_to_attend_study_visits; allergy_to_adhesive_or_alcohol; skin_conditions_compatible_with_cgm; acetaminophen_or_hydroxyurea_use; pregnancy_status; participation_in_other_trials
17163115,NCT06864546_Glutotrack,INELIGIBLE,"Patient is 37 years old (inclusion criteria: 40-70). Patient uses insulin, an oral steroid (prednisone), and a beta blocker (nadolol) which are all exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Physical activity level
19880520,DECLARE_TIMI58,ELIGIBLE,"Patient is 66 years old, has Type 2 Diabetes, and has diabetic peripheral angiopathy and kidney failure suggesting high risk for cardiovascular events. Patient does not have Type 1 diabetes and is male.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections
19880520,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",Smartphone Compatibility; Personal CGM use in the past 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Intended use of > 4g acetaminophen/day or hydroxyurea; Current participation in another interventional clinical trial; Willing and able to wear CGM; Willing and able to make diet/lifestyle modifications; Able to read and understand English; Able to attend study visits
19880520,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, which violates the inclusion criteria requiring non-insulin treated T2D.",Duration of diabetes diagnosis; Level of physical activity
18245926,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, diagnosed with Type 2 Diabetes, and has multiple risk factors indicating high cardiovascular risk. Exclusion criteria do not appear to be met.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
18245926,NCT05928572_CGM_Initiation,UNCERTAIN,"Patient's HbA1c is missing, which is a key inclusion criterion. Furthermore, information about prior CGM usage, willingness to use a smartphone, and other factors are missing. Significant comorbidities could also make the patient unsuitable.",HbA1c; Personal cellular-plan or wifi-connected smartphone; Prior CGM usage within 90 days; Willingness and ability to wear CGM and use associated mobile apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements; Dosage of Acetaminophen; Current participation in another clinical trial
18245926,NCT06864546_Glutotrack,INELIGIBLE,"The patient is 91 years old, which is outside the age range (40-70) specified in the inclusion criteria. Furthermore, the patient has a history of myocardial infarction, coronary angioplasty, atrial fibrillation and is taking a beta blocker, all of which are listed as exclusion criteria.",Physical activity level (minutes/week of moderate activity); Duration of diabetes diagnosis; HbA1c; Use of an electronic pacemaker
11954049,DECLARE_TIMI58,ELIGIBLE,"The patient is 58 years old, diagnosed with Type 2 Diabetes, and likely at high risk for cardiovascular events given their comorbidities and medications. The patient does not have any listed exclusion criteria.",
11954049,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.31%, which falls outside the inclusion criterion of 7.0%-10.0%. Additionally, the patient is taking insulin, which is an exclusion criterion. Also the patient is on oral hypoglycemic medications, but it is unclear if they carry a known hypoglycemia risk. ",
11954049,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and takes beta blockers (CARVedilol and Atenolol) and amLODIPine, and most likely has symptomatic heart disease. All are exlcusion criteria. ",Duration of diabetes diagnosis; Confirmation regarding neurostimulator type and purpose; Level of physical activity
18147745,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has Type 2 Diabetes, and has multiple cardiovascular comorbidities indicating high risk. The patient also does not have any exclusion criteria.",
18147745,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.7%, which is outside of the required range of 7.0%-10.0%. The patient is also currently taking insulin, which is an exclusion criterion.",Smartphone availability and compatibility with CGM apps; History of CGM use within the past 90 days; Willingness and ability to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Investigator's assessment of suitability based on comorbidities
18147745,NCT06864546_Glutotrack,INELIGIBLE,"Patient is ineligible due to insulin use, exceeding age limit, symptomatic heart disease, oral steroid use, and beta blocker use.",Duration of diabetes diagnosis
13835898,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has type 2 diabetes, and several comorbidities indicate a high risk for cardiovascular events. There is no indication of any exclusion criteria being met.",History of bladder cancer or radiation therapy to lower abdomen/pelvis; History of chronic cystitis or recurrent UTIs
13835898,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin (Insulin Human Regular; Insulin; Vial), which is an exclusion criterion.",
13835898,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has an HbA1c of 9.7% (above the 8.5% limit), and has a history of heart failure, TIA/cerebral infarction, atrial fibrillation and uses medications that significantly lowers heart rate (Carvedilol, Clonidine and Metoprolol Tartrate).",Duration of diabetes diagnosis; Physical activity level; Oral steroid use; Pacemaker use
15090349,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes, and has high risk factors for cardiovascular events. No exclusion criteria are met based on provided data.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; Chronic cystitis and/or recurrent urinary tract infections; Confirmation of informed consent
15090349,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Has a personal cellular-plan or wifi-connected smartphone that is compatible with required CGM apps and which will be consistently available for duration of the study; Has not used a personal CGM system within 90 days; Willing and able to wear CGM and use the associated CGM mobile apps throughout the duration of the study; Willing and able to make diet/lifestyle modifications in response to CGM data; Able to read and understand English; Able to attend study visits and complete the requirements of study; Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin; Skin conditions that are not compatible with CGM wear; Current participation in another interventional clinical trial
15090349,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a HbA1c of 9.1 (above the inclusion criteria limit of 8.5), has a history of myocardial infarction and is taking beta blockers, all of which are exclusion criteria.",Diabetes diagnosis date; Level of physical activity
14722991,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria. High risk of cardiovascular events is likely based on comorbidities. However, bladder cancer/radiation therapy and chronic cystitis/recurrent UTI history are unknown, which are exclusion criteria.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; History of chronic cystitis; History of recurrent urinary tract infections; Confirmation of informed consent
14722991,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
14722991,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin and has a history of myocardial infarction, coronary angioplasty, atrial fibrillation, and also takes multiple medications that lower heart rate, all of which are exclusion criteria.",
10113036,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria, and has several conditions suggesting high cardiovascular risk. However, it's uncertain if the patient has chronic cystitis/recurrent UTIs, and informed consent status is unknown.",Informed consent status; History of chronic cystitis/recurrent urinary tract infections
10113036,NCT05928572_CGM_Initiation,INELIGIBLE,"Patient's HbA1c is 6.04%, which is below the required 7.0%-10.0% range. The patient is also currently taking insulin, which is an exclusion criterion.",Confirmation of stable Metformin dosage; CGM usage within the last 90 days; Confirmation of acetaminophen dosage
10113036,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently on insulin and metformin which violates the inclusion criteria. Additionally, the patient has a history of myocardial infarction, is on oral steroids, medications that lower heart rate (Metoprolol and Diltiazem), and has atrial fibrillation, all of which violate the exclusion criteria.",Physical activity level; Diabetes diagnosis date; Use of an electronic pacemaker
18161880,DECLARE_TIMI58,UNCERTAIN,Patient meets inclusion criteria. Uncertainty exists regarding exclusion criteria related to bladder cancer/radiation therapy history and chronic cystitis/recurrent UTIs.,History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
18161880,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion.",
18161880,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being outside the specified age range (77), having an HbA1c of 9.2, insulin use, a history of symptomatic heart disease, use of medications that lower heart rate, and atrial fibrillation.",Duration of diabetes diagnosis; Use of electronic pacemaker; Physical Activity Level
10996527,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and diabetes criteria. Patient appears to be at high risk for cardiovascular events. No exclusion criteria are obviously met, but pregnancy status needs confirmation, and informed consent has not been confirmed.",Informed consent; Pregnancy status
10996527,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and glipizide, which are exclusion criteria. The patient also has a history of hypoglycemia, which is an exclusion criterion.",
10996527,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and is also taking GlipiZIDE, has a history of myocardial infarction and angina, and is using oral steroids and a beta blocker, thus violating multiple inclusion and exclusion criteria.",Duration of diabetes diagnosis; Pregnancy Status; Use of electronic pacemaker; Physical Activity Level
17968573,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, High Risk for Cardiovascular events) and does not meet any exclusion criteria.",
17968573,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.8%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
17968573,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease, takes beta-blockers, and has a pacemaker, all of which are exclusion criteria. The patient is prescribed Glipizide, a non-metformin oral medication that violates the inclusion criteria.",Duration of diabetes diagnosis; Physical activity level
17929514,DECLARE_TIMI58,UNCERTAIN,Patient meets the age and diabetes criteria. High risk for cardiovascular events is strongly suggested by comorbidities but not explicitly stated. Pregnancy/breastfeeding status is unknown.,Confirmation of high risk for cardiovascular events; Pregnancy status; History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
17929514,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
17929514,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, which violates the inclusion criterion of being a non-insulin treated T2D patient.",
15803796,DECLARE_TIMI58,ELIGIBLE,"The patient is male, 56 years old, diagnosed with Type 2 Diabetes, and has multiple risk factors suggesting high risk for cardiovascular events. There is no indication of any exclusion criteria being met.",
15803796,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin for their Type 2 diabetes. This violates the exclusion criterion: ""Currently taking or planning to take any form of insulin, sulfonylureas, meglitinides, or other anti-hyperglycemic diabetes medication that carry a known hypoglycemia risk"".",
15803796,NCT06864546_Glutotrack,INELIGIBLE,"The patient is taking NIFEdipine (Extended Release), a calcium channel blocker, which is a medication that significantly lowers heart rate. Therefore, the patient is excluded.",
15281319,DECLARE_TIMI58,ELIGIBLE,"Patient meets the inclusion criteria for age, Type 2 diabetes, and is at high risk for cardiovascular events. Patient does not have any exclusion criteria.",
15281319,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",Smartphone compatibility with CGM apps; Prior CGM use within 90 days; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Current participation in another interventional clinical trial
15281319,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and takes Propranolol, a beta blocker, violating both the inclusion and exclusion criteria, respectively.",Duration of diabetes diagnosis; Physical activity level; Nature of functional implant
13072531,DECLARE_TIMI58,ELIGIBLE,"Patient is >=40 years old, has Type 2 Diabetes and evidence of cardiovascular disease indicating high risk. The patient does not have any listed exclusion criteria.",
13072531,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.37%, which is outside the inclusion criterion range of 7.0%-10.0%. Additionally, the patient is currently taking insulin, which is an exclusion criterion.",
13072531,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, age outside of the range, symptomatic heart disease and the use of a beta blocker (Carvedilol).",Duration of diabetes diagnosis; Pregnancy status
13382552,DECLARE_TIMI58,UNCERTAIN,"The patient has a urinary tract infection, site not specified. It is uncertain if the patient has chronic cystitis or recurrent urinary tract infections, which are exclusionary criteria.",
13382552,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin and glyburide, both of which are listed as exclusion criteria.",
13382552,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has symptomatic heart disease, uses oral steroids (prednisone), uses heart rate lowering medication, and has atrial fibrillation, all of which are exclusion criteria. ",Diabetes diagnosis date; Use of an electronic pacemaker
13901377,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40, has type 2 diabetes, and has comorbidities suggesting high risk for cardiovascular events. They do not have any exclusion criteria available in their patient data.",History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis; Chronic cystitis; Recurrent urinary tract infections
13901377,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",smartphone ownership and plan; CGM usage within 90 days; willingness to wear CGM and use apps; willingness to make lifestyle modifications; ability to read and understand English; ability to attend study visits; allergy to medical grade adhesive or isopropyl alcohol; compatibility of skin condition with CGM wear; acetaminophen dosage; current participation in another clinical trial
13901377,NCT06864546_Glutotrack,INELIGIBLE,"The patient's HbA1c is above 8.5%, they are an insulin user, take multiple medications that significantly lower heart rate, have a history of symptomatic heart disease, atrial fibrillation and an electronic pacemaker. All of these factors violate the inclusion/exclusion criteria.",Duration of T2D diagnosis; Level of physical activity
16425078,DECLARE_TIMI58,ELIGIBLE,"Patient is >= 40 years old, has Type 2 Diabetes, and has several comorbidities indicating high cardiovascular risk. No exclusion criteria are explicitly present in the data.",History of bladder cancer or radiation therapy to the lower abdomen or pelvis; History of chronic cystitis and/or recurrent urinary tract infections
16425078,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion for the study.",CGM usage within 90 days; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen/hydroxyurea use; Participation in other interventional clinical trial; Smartphone availability and compatibility; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete requirements
16425078,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently treated with insulin, has a history of symptomatic heart disease, and is taking Metoprolol (a beta blocker).",Duration of diabetes diagnosis; Physical Activity Level; Atrial Fibrillation Status; Pacemaker Status
10869500,DECLARE_TIMI58,ELIGIBLE,"The patient is over 40 years old, has Type 2 Diabetes, is at high risk for cardiovascular events, and does not meet any of the exclusion criteria.",
10869500,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is explicitly taking insulin and glipizide, which are both listed as exclusionary medications.",
10869500,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being older than 70 years old, using insulin, history of symptomatic heart disease, use of amiodarone, metoprolol tartrate, digoxin, and atrial fibrillation.",Date of diabetes diagnosis; Level of physical activity; Use of medications impacting glucose metabolism; Use of electronic pacemaker
13050798,DECLARE_TIMI58,ELIGIBLE,"Patient meets all inclusion criteria (age >= 40, Type 2 Diabetes, high risk for cardiovascular events) and none of the exclusion criteria (Type 1 Diabetes, bladder cancer/radiation, chronic cystitis/UTIs, pregnancy/breastfeeding).",
13050798,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.9%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
13050798,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user, has a history of symptomatic heart disease and atrial fibrillation, and is taking medications that lower heart rate (Metoprolol and Amiodarone), making them ineligible for the study.",Duration of diabetes diagnosis; Physical activity level; Use of oral steroids; Use of an electronic pacemaker
11528828,DECLARE_TIMI58,UNCERTAIN,"Patient meets age and T2DM inclusion criteria. Several comorbidities indicate high CV risk. No exclusion criteria are met. However, the patient data does not provide information about informed consent, which is required.",Informed consent status
11528828,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is taking insulin, which is an exclusion criterion. The patient's current medication list includes 'Insulin'.",
11528828,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to several factors: age over 70 (73), HbA1c above 8.5% (9.31), and use of insulin.",
14395835,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria, and appears to be at high risk for cardiovascular events. However, eligibility is uncertain due to the lack of information regarding a history of bladder cancer or radiation therapy to the lower abdomen or pelvis, and the nature (chronic/recurrent) of the urinary tract infection.",History of bladder cancer or radiation therapy to the lower abdomen/pelvis; Whether the urinary tract infection is chronic or recurrent
14395835,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",
14395835,NCT06864546_Glutotrack,INELIGIBLE,"The patient is an insulin user and has a history of symptomatic heart disease, takes Prednisone, and takes beta blockers, violating multiple exclusion criteria.",Duration of diabetes diagnosis; Physical activity level
17472951,DECLARE_TIMI58,UNCERTAIN,"Patient meets the inclusion criteria. Exclusion criteria regarding bladder cancer/radiation and pregnancy seem unlikely. The patient has a history of cystitis, but it is not clear if it is chronic or recurrent which is an exclusion criteria.",Is the patient pregnant or breastfeeding?; Is the patient's cystitis chronic or recurrent?
17472951,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.65%, which is outside the inclusion criterion of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",Smartphone compatibility with CGM apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete study requirements; Allergy to medical grade adhesive or isopropyl alcohol
17472951,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to being an insulin user, having symptomatic heart disease, atrial fibrillation, and use of an electronic pacemaker.",Duration of diabetes diagnosis; Pregnancy status; Physical activity level
10169206,DECLARE_TIMI58,INELIGIBLE,"The patient has a history of urinary tract infections, making them ineligible for the trial.",
10169206,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 5.8%, which is outside the inclusion criteria range of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
10169206,NCT06864546_Glutotrack,INELIGIBLE,"The patient is currently using insulin, has atrial fibrillation, and is taking medications that lower heart rate, all of which are exclusion criteria.",Duration of diabetes diagnosis; Pregnancy status; Use of an electronic pacemaker; Physical activity level
10002013,DECLARE_TIMI58,UNCERTAIN,"The patient meets the inclusion criteria based on age, diagnosis of Type 2 diabetes, and multiple comorbidities indicating high cardiovascular risk. However, the patient's pregnancy status is unknown, and while they have cystitis, it is not specified whether it is chronic or recurrent, making it uncertain whether the exclusion criteria related to pregnancy or chronic cystitis/recurrent UTIs are met.",Pregnancy status; Is the patient's cystitis chronic or recurrent?
10002013,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient is currently taking insulin, which is an exclusion criterion.",Stability of Metformin dose; Smartphone access and compatibility; CGM usage in the last 90 days; Willingness to wear CGM and use associated apps; Willingness to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits and complete study requirements; Allergies to medical grade adhesive or isopropyl alcohol; Skin conditions; Acetaminophen dosage; Pregnancy status; Participation in other interventional trials; Investigator assessment of suitability
10002013,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, HbA1c above 8.5%, likely presence of symptomatic heart disease, and use of beta-blockers (Atenolol, Metoprolol Tartrate, Metoprolol Succinate XL, and Carvedilol).",Physical activity level; Diabetes diagnosis date; Pregnancy status
11213229,DECLARE_TIMI58,UNCERTAIN,"The patient meets the age and diabetes criteria and appears to be at high risk for cardiovascular events. There's no indication of bladder cancer or radiation therapy. The patient is male, excluding pregnancy/breastfeeding. However, the use of multiple antibiotics suggests a possible current or recent infection, which could potentially relate to recurrent UTIs, though not explicitly stated. Missing confirmation of informed consent.",Informed consent status; History of recurrent urinary tract infections
11213229,NCT05928572_CGM_Initiation,INELIGIBLE,Patient is ineligible due to HbA1c of 6.7% (inclusion criteria requires 7.0%-10.0%) and the patient taking insulin (exclusion criteria).,Personal cellular-plan or wifi-connected smartphone compatibility with CGM apps; Prior CGM use within 90 days; Willingness and ability to wear CGM and use associated apps; Willingness and ability to make diet/lifestyle modifications; Ability to read and understand English; Ability to attend study visits; Allergy to medical grade adhesive or isopropyl alcohol; Skin conditions incompatible with CGM wear; Acetaminophen dosage; Current participation in another interventional clinical trial; Investigator's determination of suitability
11213229,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to insulin use, age exceeding the limit, and history of symptomatic heart disease as well as taking a medication that lowers heart rate (metoprolol).",diabetes diagnosis date; physical activity level; use of an electronic pacemaker
14711985,DECLARE_TIMI58,ELIGIBLE,"Patient is male, age 73, has Type 2 diabetes and high risk for cardiovascular events, and meets all inclusion criteria. No exclusion criteria are present.",
14711985,NCT05928572_CGM_Initiation,INELIGIBLE,"The patient's HbA1c is 6.27, which is outside the inclusion criteria of 7.0%-10.0%. Also, the patient is currently taking insulin, which is an exclusion criterion.",
14711985,NCT06864546_Glutotrack,INELIGIBLE,"The patient is ineligible due to their age (73, exceeds the maximum of 70), insulin use, existing heart conditions (hypertensive heart disease with heart failure, atherosclerotic heart disease of native coronary artery without angina pectoris, Chronic systolic (congestive) heart failure, Acute diastolic (congestive) heart failure), taking medications that significantly impact glucose metabolism (dexamethasone), the use of medications that significantly lower heart rate (metoprolol tartrate, metoprolol succinate XL, and carvedilol), and the presence of atrial fibrillation.",Date of diabetes diagnosis; Physical activity level; Use of electronic pacemaker
